Nutraceutical Gummies Market by Type (B2B, B2C), Product Type (Vitamins, Minerals, Omega-3 Fatty Acids), Consumer Type, Production Capacity, Ingredient Source, Functionality, Demographics, Sales Channel, and Region – Global Forecast to 2030

icon1
USD 47.80 BN
MARKET SIZE, 2030
icon2
CAGR 14.4%
(2025-2030)
icon3
350
REPORT PAGES
icon4
300
MARKET TABLES

OVERVIEW

nutraceutical-gummies-market Overview

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

The nutraceutical gummies market is projected to reach USD 47.80 billion by 2030, up from USD 24.39 billion in 2025, at a CAGR of 14.4% over the same period. The growth of the nutraceutical gummies market is driven by increasing preference for the gummy delivery format over traditional pills and capsules, which is driving production volume and expansion in the e-commerce and DTC channels.

KEY TAKEAWAYS

  • BY REGION
    The North American nutraceutical gummies market accounted for 44.9% of revenue in 2025.
  • BY TYPE
    By type, the B2C segment is projected to grow at a CAGR of 14.4% from 2025 to 2030.
  • BY CUSTOMER TYPE (B2B)
    By customer type, the brand owners and marketing companies segment is expected to dominate the market with a share of 53.3% in 2025.
  • BY GUMMY BASE/EXCIPIENTS (B2B)
    By gummy base/excipients, the gelatin-based gummies segment is expected to hold a dominant market share.
  • BY PRODUCT TYPE (B2C)
    By product type, the vitamins segment is expected to hold a dominant market share.
  • BY SALES CHANNEL (B2B)
    By sales channel, the online segment is projected to grow at a faster rate.
  • COMPETITIVE LANDSCAPE - KEY PLAYERS
    Company Church & Dwight Co., Inc. and Haleon were identified as some of the key players in the nutraceutical gummies market (global), given their global presence and strong product footprint.
  • COMPETITIVE LANDSCAPE - CONTRACT MANUFACTURERS
    Sofgen Pharma, Catalent, Inc., and Activ'Inside, among others, have distinguished themselves among key contract manufacturers by securing strong footholds in specialized niche areas, underscoring their potential as emerging market leaders

The nutraceutical gummies market is expected to grow rapidly, driven by increased focus on preventive health and wellness, rising consumer interest in beauty and wellness, and growth in private-label and custom gummy programs.

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

This section provides an overview of the revenue shift in the nutraceutical gummies market for clients and their clients. The revenue shift for nutraceutical gummies is expected across various end users, including children, adults, and the elderly. Furthermore, at the consumer level, demand is projected to rise for natural, clean-label, healthy, and non-allergen products

nutraceutical-gummies-market Disruptions

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET DYNAMICS

Drivers
Impact
Level
  • Increasing preference for gummy delivery format over traditional pills and capsules
  • Expanding e-commerce and DTC channels
RESTRAINTS
Impact
Level
  • Complexity of maintaining batch-to-batch consistency and stability
  • High production costs and ingredient stability issues
OPPORTUNITIES
Impact
Level
  • Increasing reliance of startups and D2C brands on turnkey contract manufacturing
  • Growth of plant-based and sugar-free gummies
CHALLENGES
Impact
Level
  • Increasing audit expectations from global brand owners
  • Intense market competition and brand differentiation

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Driver: Increasing preference for gummy delivery format over traditional pills and capsules

Higher consumer acceptance, superior compliance, improved bioavailability, and lifestyle alignment are driving brands to prioritize gummies over pills and capsules. This transition is driving greater SKU conversions, increased launch frequency, and rising batch volumes, compelling companies to expand or outsource gummy manufacturing capacity, thereby fueling growth across the B2B nutraceutical gummies production ecosystem.

Restraint: Complexity of maintaining batch-to-batch consistency and stability

Achieving consistent quality and stability across gummy production batches is inherently complex due to the nature and the sensitivity of its ingredients and processes. Gummies are hydrocolloid gel matrices that depend on precise interactions between gelling agents (like gelatin or pectin), sugars, acids, and functional actives; even small variations in temperature, humidity, ingredient ratios, or water activity can significantly alter texture, chewiness, and overall product performance.

Opportunity: Increasing reliance of startups and D2C brands on turnkey contract manufacturing

The rise of startups, D2C brands, and e-commerce-based supplement companies presents a strong growth opportunity for the nutraceutical gummies B2B market, as these brands increasingly depend on turnkey contract and manufacturing partners to bring products to market quickly and efficiently.

Challenge: Increasing audit expectations from global brand owners

As nutraceutical gummies gain prominence in global wellness portfolios, contract manufacturers face increasingly stringent audit and compliance expectations from brand owners and regulatory stakeholders, making quality assurance a complex, resource-intensive challenge.

NUTRACEUTICAL GUMMIES MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
Offers a wide range of gummies targeting immunity, cognitive health, and wellness, combining taste and functional benefits Strengthens brand leadership | Drives consumer loyalty | Captures high-demand wellness segments
Provides age-specific and personalized gummy supplements for adults and children through a direct-selling model Expands reach | Enhances customer engagement | Builds recurring sales through personalized nutrition solutions
Produces gummies for vitamins and minerals targeting general health, energy, and immunity in adults and children Maintains strong US market presence | Increases consumer trust | Ensures high brand recognition
Develops plant-based and sugar-free gummies targeting wellness, beauty, and immune support, with global distribution. Captures emerging health-conscious consumers | Differentiates via innovative formulations | Expands international reach
Introduces gummy supplements with functional ingredients focusing on preventive health and clean-label products Enhances innovation reputation | Aligns with consumer health trends | Expands portfolio in the functional nutrition segment

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET ECOSYSTEM

The nutraceutical gummies ecosystem comprises contract manufacturers, key brand manufacturers, regulatory bodies, and research and academic institutions. The nutraceutical gummies market is a dynamic and rapidly expanding ecosystem characterized by diverse stakeholders and innovative products. Established companies and agile startups are central to this market, and they develop nutraceutical gummy products.

nutraceutical-gummies-market Ecosystem

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET SEGMENTS

nutraceutical-gummies-market Segments

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Nutraceutical Gummies Market, By Product Type (b2C)

Vitamin and mineral gummies account for the largest share of the nutraceutical gummies market due to their widespread appeal and essential role in daily nutrition.

Nutraceutical Gummies Market, By Demographics (b2C)

Generation Z (13–28 years) accounts for the largest share of the nutraceutical gummies market, owing to a strong focus on preventive health, wellness, and personalized nutrition, which drives higher consumption of gummy-based supplements compared to traditional tablets or capsules

Nutraceutical Gummies Market, By Ingredient Source (B2B)

In the nutraceutical gummies market, the plant-based ingredient segment is projected to grow the fastest during the forecast period. This surge is driven by the rising preference for vegan, allergen-free, and sustainable formulations, as consumers increasingly seek alternatives to gelatin-based gummies.

Nutraceutical Gummies Market, By Gummy Base/ Excipients (B2B)

Gelatin-based gummies account for a major share in the market, supported by superior gelling strength, elasticity, and mouthfeel, while being highly compatible with a wide range of active ingredients and established manufacturing processes.

REGION

Asia Pacific is projected to grow at the highest CAGR during the forecast period

The Asia Pacific region is witnessing the fastest growth in the nutraceutical gummies market. Consumers in this region are becoming increasingly aware of the importance of preventive healthcare and are actively seeking convenient, enjoyable, and functional supplement formats that fit into their busy lifestyles. The rise of retail chains, supermarkets, pharmacies, and e-commerce has increased access to nutraceutical gummies, boosting adoption in urban and semi-urban areas. Cultural trends in wellness, beauty, and holistic health lead brands to launch region-specific products. Supportive policies, interest in plant-based and clean-label items, and the younger, open-minded population accelerate market growth.

nutraceutical-gummies-market Region

NUTRACEUTICAL GUMMIES MARKET: COMPANY EVALUATION MATRIX

In the nutraceutical gummies market matrix, Church & Dwight Co., Inc. and Haleon (Star) lead with moderate market share and extensive product footprints, driven by their strong geographical presence, significant formulation and distribution capabilities, and strong ties with suppliers and distributors. PharmaCare Laboratories Australia (Emerging Leader) is gaining visibility with its specialized nutraceutical gummy offerings, strengthening its position through high-quality products.

nutraceutical-gummies-market Evaluation Metrics

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

KEY MARKET PLAYERS

MARKET SCOPE

REPORT METRIC DETAILS
Market Size in 2024 (Value) USD 21.44 Billion
Market Size in 2030 (Value) USD 47.80 Billion
Growth Rate CAGR of 14.4% from 2025 to 2030
Years Considered 2021–2030
Base Year 2024
Forecast Period 2025–2030
Units Considered Value (USD Million/Billion), Volume (KT)
Report Coverage Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, and Trends
Segments Covered
  • Type: B2B Market and B2C Market
  • Customer Type (B2B):
    • Brand Owners and Marketing Companies
    • Retailers and Distributors
    • Healthcare and Wellness Providers
    • Pharmaceutical Companies
    • and Food & Beverage Companies
  • Production Capacity (B2B):
    • Small-Scale Contract Manufacturers (< 10 M Units/Year)
    • Mid-Scale Manufacturers (10–50 M Units/Year)
    • and Large-Scale Industrial Manufacturers (50 M+ Units/Year)
  • Ingredient Source (B2B):
    • Animal-Based Source
    • Plant-Based Source
    • Microbial/Fermentation Derived Sources
    • and Synthetic/Chemically Derived Sources
  • Gummy Base/Excipients (B2B):
    • Gelatin-Based Gummies
    • Pectin-Based Gummies
    • Starch-Based Gummies
    • Agar
    • Carrageenan
    • and Other Hydrocolloids
  • Product Type (B2C):
    • Vitamins
    • Minerals
    • Omega-3 Fatty Acids
    • Probiotics and Prebiotics
    • Collagen and Beauty-From-Within
    • Herbal and Botanical Supplements
    • Dietary Fiber
    • CBD and Cannabis-Derived
    • and Specialty Formulations
  • Functionality (B2C):
    • Immunity Support
    • General Health & Wellness
    • Bone & Joint Health
    • Weight Management
    • Beauty & Skin Health
    • and Other Functionality
  • Demographics (B2C):
    • Generation Alpha (0–12 Years)
    • Generation Z (13–28 Years)
    • Millennials (Gen Y) (29–44 Years)
    • Generation X (45–60 Years)
    • and Baby Boomers & Older (61+ Years)
  • Sales Channel (B2C): Offline and Online
Regions Covered North America, Europe, Asia Pacific, South America, and Rest of the World

WHAT IS IN IT FOR YOU: NUTRACEUTICAL GUMMIES MARKET REPORT CONTENT GUIDE

nutraceutical-gummies-market Content Guide

DELIVERED CUSTOMIZATIONS

We have successfully delivered the following deep-dive customizations:

CLIENT REQUEST CUSTOMIZATION DELIVERED VALUE ADDS
Gummy Supplement Manufacturers & Brand Owners
  • Quality & safety benchmarking by product type (vitamins, minerals, collagen, CBD, herbal/probiotic)
  • Regulatory compliance matrix by region
  • Stability, shelf-life, and contamination risk profiles for formulations
  • Faster compliance and market entry
  • Reduced product recalls and safety risks
  • Enhanced formulation quality and consumer trust
Analytical & Testing Labs
  • Technology adoption roadmap (manual vs automated testing for gummies)
  • Accuracy & throughput benchmarking of testing methods
  • Updates on regional testing protocols and regulatory impacts
  • Optimized lab workflows and efficiency
  • Competitive differentiation through validated services
  • Alignment with emerging regulations and standards
Regulatory Authorities & Food Safety Agencies
  • Comprehensive review of testing standards for gummy supplements
  • Data on contaminants, heavy metals, allergens, and adulterants
  • Compliance reporting frameworks for manufacturers and retailers
  • Improved oversight and enforcement effectiveness
  • Streamlined regulatory processes
  • Enhanced consumer safety and public health protection

RECENT DEVELOPMENTS

  • May 2025 : Otsuka Holdings Co., Ltd, inaugurated a new USD 250 million, 225,000-square-foot manufacturing and R&D facility in New Albany, Ohio. This marks its first investment in the region, creating 225 jobs and expanding production of vitamin gummies to meet rising consumer demand. The facility also houses the Gummies Innovation Center of Excellence, which enhances research capabilities and reinforces Pharmavite’s leadership in the supplement industry. The company aims to be a strong community partner while contributing to Central Ohio’s growth in health and life sciences.
  • January 2025 : Nature’s Way Brands reformulated eight core products in its Alive! Multivitamin line—available in both tablet and gummy formats—by adding a Superfood Antioxidant Powder Blend made from carrots, pomegranate extract, blueberries, spinach, and apple extract. This enhancement aims to address nutritional gaps and support general wellness by combining essential vitamins (C, E, beta-carotene) with plant-based polyphenols. The reformulated gummies deliver 50 mg of the blend per 2-gummy serving and are priced at USD 12.49, available nationwide from January 2025.
  • September 2024 : Unilever invested USD 5 million in Create Wellness, a US-based startup known for its gummy creatine supplements, as part of its series A funding round. This strategic move supports Unilever’s expansion into the health and wellness sector, aiming to diversify its portfolio and boost innovation in functional nutrition.

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
1
INTRODUCTION
 
 
 
 
 
49
2
EXECUTIVE SUMMARY
 
 
 
 
 
55
3
PREMIUM INSIGHTS
 
 
 
 
 
61
4
MARKET OVERVIEW
Gummy supplement market thrives on innovation, personalized nutrition, and rising consumer wellness trends.
 
 
 
 
 
66
 
4.1
INTRODUCTION
 
 
 
 
 
 
4.2
MARKET DYNAMICS
 
 
 
 
 
 
 
4.2.1
DRIVERS
 
 
 
 
 
 
 
4.2.1.1
RISING RATE OF VITAMIN-DEFICIENCY DISEASES AND UNDERNUTRITION
 
 
 
 
 
 
4.2.1.2
GROWING CONSUMER INTEREST IN BEAUTY AND WELLNESS
 
 
 
 
 
 
4.2.1.3
INNOVATION IN FUNCTIONAL FORMULATIONS
 
 
 
 
 
 
4.2.1.4
GROWTH IN GUMMY SUPPLEMENT LAUNCHES AND CUSTOM GUMMY PROGRAMS
 
 
 
 
 
 
4.2.1.5
INCREASING PREFERENCE FOR GUMMY DELIVERY FORMAT OVER TRADITIONAL PILLS AND CAPSULES
 
 
 
 
 
4.2.2
RESTRAINTS
 
 
 
 
 
 
 
4.2.2.1
REGULATORY COMPLEXITIES ACROSS REGIONS
 
 
 
 
 
 
4.2.2.2
SUGAR CONTENT AND HEALTH CONCERNS
 
 
 
 
 
 
4.2.2.3
INGREDIENT SOURCING VOLATILITY
 
 
 
 
 
 
4.2.2.4
COMPLEXITY IN MAINTAINING BATCH-TO-BATCH CONSISTENCY AND STABILITY
 
 
 
 
 
4.2.3
OPPORTUNITIES
 
 
 
 
 
 
 
4.2.3.1
RISING POPULARITY OF PLANT-BASED AND SUGAR-FREE GUMMIES
 
 
 
 
 
 
4.2.3.2
EXPANSION INTO PERSONALIZED AND AI-DRIVEN NUTRITION
 
 
 
 
 
 
4.2.3.3
INCREASING RELIANCE OF STARTUPS AND D2C BRANDS ON TURNKEY CONTRACT MANUFACTURING
 
 
 
 
 
 
4.2.3.4
GEOGRAPHIC EXPANSION WITH LOCALIZED FORMULATION EXPERTISE
 
 
 
 
 
4.2.4
CHALLENGES
 
 
 
 
 
 
 
4.2.4.1
LIMITED BIOAVAILABILITY AND NUTRIENT DEGRADATION
 
 
 
 
 
 
4.2.4.2
INTENSE MARKET COMPETITION AND BRAND DIFFERENTIATION
 
 
 
 
 
 
4.2.4.3
LOGISTICS ISSUES: MELTING, DEFORMATION, AND TRANSIT STABILITY
 
 
 
 
 
 
4.2.4.4
INCREASING AUDIT EXPECTATIONS FROM GLOBAL BRAND OWNERS
 
 
 
 
4.3
UNMET NEEDS AND WHITE SPACES
 
 
 
 
 
 
 
4.3.1
UNMET NEEDS IN NUTRACEUTICAL GUMMIES MARKET
 
 
 
 
 
 
4.3.2
WHITE SPACE OPPORTUNITIES
 
 
 
 
 
4.4
INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
 
 
 
 
 
 
 
4.4.1
INTERCONNECTED MARKETS
 
 
 
 
 
 
4.4.2
CROSS-SECTOR OPPORTUNITIES
 
 
 
 
 
4.5
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
 
 
 
 
 
 
 
4.5.1
KEY MOVES AND STRATEGIC FOCUS
 
 
 
 
5
INDUSTRY TRENDS
US-China tariffs and inflation reshape competitive dynamics in the nutraceutical gummies market.
 
 
 
 
 
81
 
5.1
PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
 
 
 
5.1.1
INTENSITY OF COMPETITIVE RIVALRY
 
 
 
 
 
 
5.1.2
BARGAINING POWER OF SUPPLIERS
 
 
 
 
 
 
5.1.3
BARGAINING POWER OF BUYERS
 
 
 
 
 
 
5.1.4
THREAT OF SUBSTITUTES
 
 
 
 
 
 
5.1.5
THREAT OF NEW ENTRANTS
 
 
 
 
 
5.2
MACROECONOMICS OUTLOOK
 
 
 
 
 
 
 
5.2.1
INTRODUCTION
 
 
 
 
 
 
 
5.2.1.1
MACROECONOMIC INDICATORS - B2C MARKET
 
 
 
 
 
 
 
 
5.2.1.1.1
US-CHINA TRADE TARIFF FLUCTUATIONS RESHAPE NUTRACEUTICAL GUMMIES MARKET
 
 
 
 
 
 
5.2.1.1.2
INFLATION AND RAW MATERIAL COSTS RESHAPE NUTRACEUTICAL GUMMIES MARKET
 
 
 
 
5.2.1.2
MACROECONOMIC INDICATORS - B2B MARKET
 
 
 
 
 
 
 
 
5.2.1.2.1
POPULATION AGING AND CHRONIC DISEASE BURDEN INFLUENCING PREVENTIVE HEALTH AND NUTRACEUTICAL MARKET EXPANSION
 
 
5.3
VALUE CHAIN ANALYSIS
 
 
 
 
 
 
 
 
5.3.1
RAW MATERIAL & FUNCTIONAL INGREDIENT SOURCING
 
 
 
 
 
 
5.3.2
PRODUCT DEVELOPMENT AND MANUFACTURING
 
 
 
 
 
 
5.3.3
QUALITY, SAFETY, AND REGULATORY COMPLIANCE
 
 
 
 
 
 
5.3.4
PACKAGING & LABEL CUSTOMIZATION
 
 
 
 
 
 
5.3.5
MARKETING AND DISTRIBUTION
 
 
 
 
 
 
5.3.6
END USERS
 
 
 
 
 
5.4
ECOSYSTEM ANALYSIS
 
 
 
 
 
 
 
 
5.4.1
DEMAND SIDE
 
 
 
 
 
 
5.4.2
SUPPLY SIDE
 
 
 
 
 
5.5
PRICING ANALYSIS
 
 
 
 
 
 
 
 
5.5.1
AVERAGE SELLING PRICE (ASP) OF NUTRACEUTICAL GUMMIES, BY KEY PLAYER
 
 
 
 
 
 
5.5.2
AVERAGE SELLING PRICE (ASP) TREND OF NUTRACEUTICAL GUMMIES, BY REGION
 
 
 
 
 
5.6
TRADE ANALYSIS
 
 
 
 
 
 
 
 
5.6.1
EXPORT SCENARIO OF HS CODE 210690, BY KEY COUNTRY, 2020–2024 (MT)
 
 
 
 
 
 
5.6.2
IMPORT SCENARIO OF HS CODE 210690, BY KEY COUNTRY, 2020–2024 (MT)
 
 
 
 
 
5.7
KEY CONFERENCES AND EVENTS, 2026–2027
 
 
 
 
 
 
5.8
TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
 
 
 
 
 
 
5.9
INVESTMENT AND FUNDING SCENARIO
 
 
 
 
 
 
5.10
CASE STUDY ANALYSIS
 
 
 
 
 
 
 
5.10.1
NESTLÉ HEALTH SCIENCE – EXPANDED COLLAGEN & FUNCTIONAL PORTFOLIO THROUGH MAJORITY STAKE ACQUISITION OF VITAL PROTEINS
 
 
 
 
 
 
5.10.2
SIRIO PHARMA – EXPANDING NUTRACEUTICAL GUMMY AND PLANT-BASED SOFTGEL MANUFACTURING THROUGH ACQUISITION OF BEST FORMULATIONS
 
 
 
 
 
 
5.10.3
TOPGUM INDUSTRIES – EXPANDING PHARMA GRADE AND HIGH VOLUME GUMMY MANUFACTURING THROUGH ACQUISITION OF ISLAND ABBEY NUTRITIONALS
 
 
 
 
 
 
5.10.4
GILLCO/IFF GRINDSTED – ENHANCING GUMMY GELATION AND PROCESS STABILITY USING SLOW-SET PECTIN
 
 
 
 
 
5.11
IMPACT OF 2025 US TARIFF – NUTRACEUTICAL GUMMIES MARKET
 
 
 
 
 
 
 
 
5.11.1
INTRODUCTION
 
 
 
 
 
 
5.11.2
KEY TARIFF RATES
 
 
 
 
 
 
5.11.3
PRICE IMPACT ANALYSIS
 
 
 
 
 
 
5.11.4
IMPACT ON COUNTRIES/REGIONS
 
 
 
 
 
 
 
5.11.4.1
US
 
 
 
 
 
 
5.11.4.2
EUROPE
 
 
 
 
 
 
5.11.4.3
ASIA PACIFIC
 
 
 
 
 
5.11.5
IMPACT ON END-USE INDUSTRIES
 
 
 
 
6
TECHNOLOGY ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
Generative AI and 3D printing revolutionize personalized, sustainable nutraceutical gummy production.
 
 
 
 
 
107
 
6.1
TECHNOLOGY ANALYSIS
 
 
 
 
 
 
 
6.1.1
KEY TECHNOLOGIES
 
 
 
 
 
 
 
6.1.1.1
GELLING AND TEXTURE TECHNOLOGY
 
 
 
 
 
 
 
 
6.1.1.1.1
STARCH-BASED GELLING TECHNOLOGY
 
 
 
 
 
 
6.1.1.1.2
STARCHLESS GELLING TECHNOLOGY
 
 
 
 
6.1.1.2
MICROENCAPSULATION TECHNOLOGY (TASTE MASKING & FLAVOR)
 
 
 
 
 
6.1.2
COMPLEMENTARY TECHNOLOGIES
 
 
 
 
 
 
 
6.1.2.1
COATING TECHNOLOGY
 
 
 
 
 
 
6.1.2.2
NUTRIENT STABILIZATION METHODS
 
 
 
 
 
 
6.1.2.3
FLAVOR RELEASE SYSTEMS
 
 
 
 
 
6.1.3
ADJACENT TECHNOLOGIES
 
 
 
 
 
 
 
6.1.3.1
3D-PRINTING & PERSONALIZED DOSING PLATFORMS
 
 
 
 
 
 
6.1.3.2
PLANT-BASED AND CLEAN-LABEL INGREDIENT TECHNOLOGIES
 
 
 
 
 
 
6.1.3.3
SMART PACKAGING
 
 
 
 
6.2
TECHNOLOGY/PRODUCT ROADMAP
 
 
 
 
 
 
 
6.2.1
SHORT-TERM | FOUNDATION & EARLY COMMERCIALIZATION
 
 
 
 
 
 
6.2.2
MID-TERM | EXPANSION & STANDARDIZATION
 
 
 
 
 
 
6.2.3
LONG-TERM | PRECISION NUTRITION & SMART CALCIUM SOLUTIONS
 
 
 
 
 
6.3
PATENT ANALYSIS
 
 
 
 
 
 
 
6.4
FUTURE APPLICATIONS
 
 
 
 
 
 
 
6.4.1
GELATIN-FREE, REDUCED-SUGAR FUNCTIONAL GUMMIES ENRICHED WITH PGH EXTRACT
 
 
 
 
 
 
6.4.2
MICROENCAPSULATION OF VITAMIN C FOR IMPROVED STABILITY IN NUTRACEUTICAL GUMMIES
 
 
 
 
 
 
6.4.3
3D-PRINTED PATIENT-TAILORED MEDICINAL GUMMIES FOR PEDIATRIC DRUG DELIVERY
 
 
 
 
 
 
6.4.4
EDIBLE ACTIVE PACKAGING AS SMART PACKAGING FOR NUTRACEUTICAL GUMMIES
 
 
 
 
 
 
6.4.5
IOT-ENABLED SMART MANUFACTURING AND ITS FUTURE APPLICATION IN NUTRACEUTICAL GUMMY PRODUCTION
 
 
 
 
 
6.5
IMPACT OF GENERATIVE AI ON NUTRACEUTICAL GUMMIES MARKET
 
 
 
 
 
 
 
6.5.1
INTRODUCTION
 
 
 
 
 
 
6.5.2
USE OF GENERATIVE AI ON NUTRACEUTICAL GUMMIES MARKET
 
 
 
 
 
 
6.5.3
TOP USE CASES AND MARKET POTENTIAL
 
 
 
 
 
 
6.5.4
BEST PRACTICES IN NUTRACEUTICAL INDUSTRY
 
 
 
 
 
 
6.5.5
CASE STUDIES OF AI IMPLEMENTATION IN NUTRACEUTICAL GUMMIES MARKET
 
 
 
 
 
 
6.5.6
INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
 
 
 
 
 
 
6.5.7
CLIENTS’ READINESS TO ADOPT GENERATIVE AI NUTRACEUTICAL GUMMIES
 
 
 
 
7
REGULATORY LANDSCAPE AND SUSTAINABILITY INITIATIVES
Navigate evolving regulations and sustainability for future-proof nutraceutical compliance and eco-friendly innovation.
 
 
 
 
 
121
 
7.1
REGIONAL REGULATIONS AND COMPLIANCE
 
 
 
 
 
 
 
7.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
7.1.2
INDUSTRY STANDARDS
 
 
 
 
 
 
7.1.3
LABELING REQUIREMENTS AND CLAIMS
 
 
 
 
 
 
7.1.4
ANTICIPATED REGULATORY CHANGES IN NEXT 5–10 YEARS
 
 
 
 
 
 
 
7.1.4.1
MANDATORY VALIDATION OF BIOAVAILABILITY & FUNCTIONAL CLAIMS
 
 
 
 
 
 
7.1.4.2
GLOBAL HARMONIZATION OF DIETARY SUPPLEMENT & NUTRACEUTICAL CLASSIFICATIONS
 
 
 
 
 
 
7.1.4.3
STRENGTHENED SAFETY, CONTAMINANT, & ADDITIVE CONTROL REGULATIONS
 
 
 
 
 
 
7.1.4.4
DIGITAL LABELING, TRACEABILITY & QR-BASED COMPLIANCE TRACKING
 
 
 
 
7.2
SUSTAINABILITY INITIATIVES
 
 
 
 
 
 
 
7.2.1
SUSTAINABLE SOURCING
 
 
 
 
 
 
7.2.2
CARBON FOOTPRINT REDUCTION INITIATIVES
 
 
 
 
 
 
7.2.3
CIRCULAR ECONOMY APPROACHES
 
 
 
 
 
7.3
IMPACT OF REGULATORY POLICIES ON SUSTAINABILITY INITIATIVES
 
 
 
 
 
 
7.4
CERTIFICATIONS, LABELING, ECO-STANDARDS
 
 
 
 
 
8
CUSTOMER LANDSCAPE AND BUYER BEHAVIOR
Unlock profitability by understanding key stakeholder criteria and unmet needs in nutraceutical gummies market.
 
 
 
 
 
129
 
8.1
DECISION-MAKING PROCESS
 
 
 
 
 
 
8.2
KEY STAKEHOLDERS INVOLVED IN BUYING PROCESS AND THEIR EVALUATION CRITERIA
 
 
 
 
 
 
 
8.2.1
KEY STAKEHOLDERS IN BUYING PROCESS
 
 
 
 
 
 
8.2.2
BUYING CRITERIA
 
 
 
 
 
8.3
ADOPTION BARRIERS AND INTERNAL CHALLENGES
 
 
 
 
 
 
8.4
UNMET NEEDS OF VARIOUS APPLICATION INDUSTRIES ACROSS SUPPLY CHAIN
 
 
 
 
 
 
8.5
MARKET PROFITABILITY
 
 
 
 
 
 
8.6
REVENUE POTENTIAL
 
 
 
 
 
 
 
8.6.1
COST DYNAMICS
 
 
 
 
 
 
8.6.2
MARGIN OPPORTUNITIES, BY TYPE
 
 
 
 
9
NUTRACEUTICAL GUMMIES MARKET, BY TYPE
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million and Tons | 4 Data Tables
 
 
 
 
 
137
 
9.1
INTRODUCTION
 
 
 
 
 
 
9.2
B2C MARKET
 
 
 
 
 
 
 
9.2.1
ADVANCING CONSUMER HEALTH THROUGH FUNCTIONAL GUMMIES
 
 
 
 
 
9.3
B2B MARKET
 
 
 
 
 
 
 
9.3.1
POWERING BRANDS WITH SCALABLE, SCIENCE-DRIVEN GUMMY SOLUTIONS
 
 
 
 
10
NUTRACEUTICAL GUMMIES MARKET (B2B), BY CUSTOMER TYPE
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 12 Data Tables
 
 
 
 
 
140
 
10.1
INTRODUCTION
 
 
 
 
 
 
10.2
BRAND OWNERS & MARKETING COMPANIES
 
 
 
 
 
 
 
10.2.1
DEMAND FOR DIFFERENTIATED, CLEAN-LABEL, AND TREND-RESPONSIVE GUMMY FORMULATIONS TO BENEFIT CONTRACT MANUFACTURERS AND PRIVATE-LABEL PARTNERS
 
 
 
 
 
10.3
RETAILERS & DISTRIBUTORS
 
 
 
 
 
 
 
10.3.1
RAPID EXPANSION OF PRIVATE-LABEL SUPPLEMENTS AND OMNICHANNEL RETAIL STRATEGIES TO INCREASE RETAILER DEMAND FOR COST-EFFICIENT, HIGH-QUALITY GUMMY MANUFACTURING PARTNERSHIPS
 
 
 
 
 
10.4
HEALTHCARE & WELLNESS
 
 
 
 
 
 
 
10.4.1
GROWING INTEGRATION OF NUTRITION INTO PREVENTIVE CARE, PEDIATRICS, AND WELLNESS PROGRAMS TO DRIVE DEMAND FOR CLINICALLY CREDIBLE, COMPLIANCE-FRIENDLY GUMMY SUPPLEMENTS
 
 
 
 
 
10.5
PHARMACEUTICAL COMPANIES
 
 
 
 
 
 
 
10.5.1
PHARMACEUTICAL PLAYERS LEVERAGE NUTRACEUTICAL GUMMIES TO EXTEND CONSUMER HEALTH PORTFOLIOS BEYOND PRESCRIPTIONS WHILE MAINTAINING CLINICAL CREDIBILITY AND QUALITY DIFFERENTIATION
 
 
 
 
 
10.6
FOOD & BEVERAGE COMPANIES
 
 
 
 
 
 
 
10.6.1
CONVERGENCE OF INDULGENCE AND FUNCTIONALITY PROMPTING CONFECTIONERY AND FOOD COMPANIES TO EXPLORE FUNCTIONAL GUMMIES
 
 
 
 
11
NUTRACEUTICAL GUMMIES MARKET (B2B), BY PRODUCTION CAPACITY
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 8 Data Tables
 
 
 
 
 
154
 
11.1
INTRODUCTION
 
 
 
 
 
 
11.2
SMALL-SCALE CONTRACT MANUFACTURERS (<10 M UNITS/YEAR)
 
 
 
 
 
 
 
11.2.1
GROWING DEMAND FOR LOW-VOLUME, CUSTOMIZED GUMMY FORMULATIONS TO SUPPORT EMERGING NUTRACEUTICAL BRANDS
 
 
 
 
 
11.3
MID-SCALE MANUFACTURERS (10–50 M UNITS/YEAR)
 
 
 
 
 
 
 
11.3.1
INCREASING NEED FOR SCALABLE PRODUCTION WITH FORMULATION FLEXIBILITY TO SUPPORT BRAND EXPANSION AND REGIONAL MARKET PENETRATION
 
 
 
 
 
11.4
LARGE-SCALE INDUSTRIAL MANUFACTURERS (50+ M UNITS/YEAR)
 
 
 
 
 
 
 
11.4.1
RISING REQUIREMENT FOR HIGH-VOLUME, STANDARDIZED GUMMY PRODUCTION TO ENSURE SUPPLY CONSISTENCY FOR GLOBAL NUTRACEUTICAL BRANDS
 
 
 
 
12
NUTRACEUTICAL GUMMIES MARKET (B2B), BY INGREDIENT SOURCE
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 10 Data Tables
 
 
 
 
 
161
 
12.1
INTRODUCTION
 
 
 
 
 
 
12.2
ANIMAL-BASED SOURCES
 
 
 
 
 
 
 
12.2.1
COLLAGEN EFFICACY KEEPS ANIMAL-BASED INGREDIENTS DOMINANT
 
 
 
 
 
12.3
PLANT-BASED SOURCES
 
 
 
 
 
 
 
12.3.1
VEGAN AND CLEAN-LABEL DEMAND FUELS PLANT-BASED ADOPTION
 
 
 
 
 
12.4
MICROBIAL/FERMENTATION-DERIVED SOURCES
 
 
 
 
 
 
 
12.4.1
ADVANCEMENTS IN STABILIZED FERMENTATION TECHNOLOGIES TO EXPANDING ADOPTION OF MICROBIAL-DERIVED ACTIVES IN GUMMY FORMULATIONS
 
 
 
 
 
12.5
SYNTHETIC/CHEMICALLY-DERIVED SOURCES
 
 
 
 
 
 
 
12.5.1
CONSISTENCY AND SCALE TO SUSTAIN SYNTHETIC INGREDIENT USAGE
 
 
 
 
13
NUTRACEUTICAL GUMMIES MARKET (B2B), BY GUMMY BASE/EXCIPIENTS
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 10 Data Tables
 
 
 
 
 
172
 
13.1
INTRODUCTION
 
 
 
 
 
 
13.2
GELATIN-BASED GUMMIES
 
 
 
 
 
 
 
13.2.1
HIGH ACTIVE LOADING AND TEXTURE RELIABILITY TO CONTINUE DRIVING GELATIN USAGE
 
 
 
 
 
13.3
PECTIN-BASED GUMMIES
 
 
 
 
 
 
 
13.3.1
VEGAN POSITIONING AND CLEAN-LABEL DEMAND TO ACCELERATE PECTIN ADOPTION
 
 
 
 
 
13.4
STARCH-BASED GUMMIES
 
 
 
 
 
 
 
13.4.1
COST PRESSURE AND LARGE-SCALE PRODUCTION NEEDS TO SUSTAIN STARCH-BASED SYSTEMS
 
 
 
 
 
13.5
AGAR, CARRAGEENAN, AND OTHER HYDROCOLLOIDS
 
 
 
 
 
14
NUTRACEUTICAL GUMMIES MARKET (B2C), BY PRODUCT TYPE
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 54 Data Tables
 
 
 
 
 
179
 
14.1
INTRODUCTION
 
 
 
 
 
 
14.2
VITAMINS
 
 
 
 
 
 
 
14.2.1
RISING INSTANCES OF VITAMIN DEFICIENCIES TO DRIVE SEGMENT
 
 
 
 
 
 
14.2.2
MULTIVITAMINS
 
 
 
 
 
 
14.2.3
VITAMIN C
 
 
 
 
 
 
14.2.4
VITAMIN D
 
 
 
 
 
 
14.2.5
VITAMIN B COMPLEX
 
 
 
 
 
 
14.2.6
VITAMIN E AND A
 
 
 
 
 
14.3
MINERALS
 
 
 
 
 
 
 
14.3.1
MEETING ESSENTIAL MINERAL NEEDS THROUGH CONVENIENT, PALATABLE SUPPLEMENTATION FOR EVERYDAY HEALTH SUPPORT
 
 
 
 
 
 
14.3.2
CALCIUM
 
 
 
 
 
 
14.3.3
IRON
 
 
 
 
 
 
14.3.4
ZINC
 
 
 
 
 
 
14.3.5
MAGNESIUM
 
 
 
 
 
14.4
OMEGA-3 FATTY ACIDS
 
 
 
 
 
 
14.5
PROBIOTICS & PREBIOTICS
 
 
 
 
 
 
 
14.5.1
INCREASED INTEREST IN SKIN CARE AMONG CONSUMERS TO BOOST MARKET
 
 
 
 
 
14.6
COLLAGEN & BEAUTY-FROM-WITHIN
 
 
 
 
 
 
 
14.6.1
INCREASED INTEREST IN SKIN CARE AMONG CONSUMERS TO BOOST MARKET
 
 
 
 
 
14.7
HERBAL & BOTANICAL
 
 
 
 
 
 
 
14.7.1
RISING CONSUMER PREFERENCE FOR PLANT-BASED NATURAL INGREDIENTS TO DRIVE SEGMENT
 
 
 
 
 
 
14.7.2
ASHWAGANDHA
 
 
 
 
 
 
14.7.3
TURMERIC/CURCUMIN
 
 
 
 
 
 
14.7.4
ELDERBERRY
 
 
 
 
 
 
14.7.5
MELATONIN
 
 
 
 
 
 
14.7.6
OTHER HERBAL AND BOTANICAL GUMMIES
 
 
 
 
 
14.8
DIETARY FIBER
 
 
 
 
 
 
14.9
CBD & CANNABIS-DERIVED
 
 
 
 
 
 
14.10
SPECIALTY FORMULATIONS
 
 
 
 
 
 
 
14.10.1
HEALTH-PROMOTING PROPERTIES TO AUGMENT SEGMENT GROWTH
 
 
 
 
15
NUTRACEUTICAL GUMMIES MARKET(B2C), BY FUNCTIONALITY
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 14 Data Tables
 
 
 
 
 
209
 
15.1
INTRODUCTION
 
 
 
 
 
 
15.2
IMMUNITY SUPPORT
 
 
 
 
 
 
 
15.2.1
RISING FOCUS ON IMPROVING IMMUNITY TO DRIVE MARKET
 
 
 
 
 
15.3
GENERAL HEALTH & WELLNESS
 
 
 
 
 
 
 
15.3.1
GROWING NUTRITIONAL DEFICIENCIES AND PREVENTIVE HEALTHCARE TRENDS TO DRIVE MARKET
 
 
 
 
 
15.4
BONE & JOINT HEALTH
 
 
 
 
 
 
 
15.4.1
RISING CASES OF OSTEOPOROSIS TO PROPEL MARKET GROWTH
 
 
 
 
 
15.5
WEIGHT MANAGEMENT
 
 
 
 
 
 
 
15.5.1
RISING PREVALENCE OF OBESITY AND METABOLIC DISORDERS TO DRIVE MARKET
 
 
 
 
 
15.6
BEAUTY & SKIN HEALTH
 
 
 
 
 
 
 
15.6.1
INCREASING FOCUS ON APPEARANCE AND OVERALL SKIN WELLNESS TO DRIVE MARKET
 
 
 
 
16
NUTRACEUTICAL GUMMIES MARKET (B2C), BY DEMOGRAPHICS
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 12 Data Tables
 
 
 
 
 
219
 
16.1
INTRODUCTION
 
 
 
 
 
 
16.2
GENERATION ALPHA (0–12 YEARS)
 
 
 
 
 
 
 
16.2.1
EARLY-LIFE SUPPLEMENTATION AND DIGITAL-FIRST PARENTING TO FUEL DEMAND FOR PEDIATRIC NUTRACEUTICAL GUMMIES
 
 
 
 
 
16.3
GENERATION Z (13–28 YEARS)
 
 
 
 
 
 
 
16.3.1
FOCUS ON HEALTH AND DAILY SELF-CARE TO FUEL GUMMY SUPPLEMENT DEMAND
 
 
 
 
 
16.4
MILLENNIALS (GEN Y) (29–44 YEARS)
 
 
 
 
 
 
 
16.4.1
LIFESTYLE-DRIVEN WELLNESS CHOICES TO POWER NUTRACEUTICAL ADOPTION
 
 
 
 
 
16.5
GENERATION X (45–60 YEARS)
 
 
 
 
 
 
 
16.5.1
WILLINGNESS TO INVEST IN HEALTH-ENHANCING NUTRITION SOLUTIONS TO DRIVE MARKET
 
 
 
 
 
16.6
BABY BOOMERS AND OLDER (61+ YEARS)
 
 
 
 
 
 
 
16.6.1
HEALTHY AGING PRIORITIES TO DRIVE NUTRACEUTICAL USE
 
 
 
 
17
NUTRACEUTICAL GUMMIES MARKET (B2C), BY DISTRIBUTION CHANNEL
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 18 Data Tables
 
 
 
 
 
228
 
17.1
INTRODUCTION
 
 
 
 
 
 
17.2
OFFLINE CHANNELS
 
 
 
 
 
 
 
17.2.1
HYPERMARKETS & SUPERMARKETS
 
 
 
 
 
 
 
17.2.1.1
PREFERRED PURCHASING DESTINATION AND AVAILABILITY OF VARIANTS TO DRIVE GROWTH
 
 
 
 
 
17.2.2
PHARMACIES & DRUGSTORES
 
 
 
 
 
 
 
17.2.2.1
WIDE PRESENCE AND AROUND-THE-CLOCK SERVICES TO DRIVE GROWTH
 
 
 
 
 
17.2.3
SPECIALTY HEALTH STORES
 
 
 
 
 
 
 
17.2.3.1
ENABLING PREMIUM AND TARGETED GUMMY SUPPLEMENT SALES
 
 
 
 
 
17.2.4
CONVENIENCE STORES
 
 
 
 
 
 
 
17.2.4.1
PREFERENCE TOWARD SPECIALIZED HEALTHCARE PRODUCTS TO FUEL GROWTH
 
 
 
 
 
17.2.5
MASS MERCHANDISERS AND MULTI-LEVEL MARKETING (MLM)
 
 
 
 
 
 
 
17.2.5.1
HIGH-VOLUME RETAIL AND NETWORK-BASED SELLING DRIVE OFFLINE EXPANSION
 
 
 
 
17.3
ONLINE CHANNELS
 
 
 
 
 
18
NUTRACEUTICAL GUMMIES MARKET, BY REGION
Comprehensive coverage of 7 Regions with country-level deep-dive of 14 Countries | 364 Data Tables.
 
 
 
 
 
239
 
18.1
INTRODUCTION
 
 
 
 
 
 
18.2
NORTH AMERICA
 
 
 
 
 
 
 
18.2.1
US
 
 
 
 
 
 
 
18.2.1.1
PRESENCE OF KEY PLAYERS AND VARIOUS HEALTH TRENDS TO BOOST MARKET
 
 
 
 
 
18.2.2
CANADA
 
 
 
 
 
 
 
18.2.2.1
CONVENIENCE, TASTE, AND HEALTH BENEFITS TO DRIVE DEMAND FOR NUTRACEUTICAL GUMMIES
 
 
 
 
 
18.2.3
MEXICO
 
 
 
 
 
 
 
18.2.3.1
RISING HEALTH-CONSCIOUS AND VEGAN POPULATION TO DRIVE MARKET
 
 
 
 
18.3
EUROPE
 
 
 
 
 
 
 
18.3.1
GERMANY
 
 
 
 
 
 
 
18.3.1.1
GROWING INTEREST IN HEALTH & WELLNESS TO DRIVE MARKET
 
 
 
 
 
18.3.2
UK
 
 
 
 
 
 
 
18.3.2.1
RISING PREVALENCE OF DISEASES TO DRIVE MARKET
 
 
 
 
 
18.3.3
FRANCE
 
 
 
 
 
 
 
18.3.3.1
HIGH HEALTHCARE COSTS AND INCREASED DEMAND FOR DIETARY SUPPLEMENTS TO DRIVE MARKET
 
 
 
 
 
18.3.4
SPAIN
 
 
 
 
 
 
 
18.3.4.1
ADOPTION OF HEALTHY LIFESTYLES TO DRIVE MARKET
 
 
 
 
 
18.3.5
ITALY
 
 
 
 
 
 
 
18.3.5.1
STRONG E-COMMERCE SYSTEM AND RISING GERIATRIC POPULATION TO DRIVE MARKET
 
 
 
 
 
18.3.6
REST OF EUROPE
 
 
 
 
 
18.4
ASIA PACIFIC
 
 
 
 
 
 
 
18.4.1
CHINA
 
 
 
 
 
 
 
18.4.1.1
LARGE POPULATION AND INCREASING PREVALENCE OF DISEASES TO DRIVE MARKET
 
 
 
 
 
18.4.2
JAPAN
 
 
 
 
 
 
 
18.4.2.1
RISING AWARENESS AND SHIFTING PREFERENCES TOWARD DIETARY SUPPLEMENTS TO DRIVE MARKET
 
 
 
 
 
18.4.3
INDIA
 
 
 
 
 
 
 
18.4.3.1
RISING DISPOSABLE INCOMES AND GROWING FOCUS ON WELLNESS TO DRIVE MARKET
 
 
 
 
 
18.4.4
AUSTRALIA & NEW ZEALAND
 
 
 
 
 
 
 
18.4.4.1
HIGH DEMAND FOR DIETARY SUPPLEMENTS, PARTICULARLY IN NEW FORMATS, TO DRIVE MARKET
 
 
 
 
 
18.4.5
REST OF ASIA PACIFIC
 
 
 
 
 
18.5
SOUTH AMERICA
 
 
 
 
 
 
 
18.5.1
BRAZIL
 
 
 
 
 
 
 
18.5.1.1
INCREASING CONSUMER PREFERENCE FOR CONVENIENT AND PALATABLE FORMATS IN NUTRIENT INTAKE TO DRIVE MARKET
 
 
 
 
 
18.5.2
ARGENTINA
 
 
 
 
 
 
 
18.5.2.1
GROWING FOCUS ON PREVENTION OF MICRONUTRIENT DEFICIENCIES AND CARDIOMETABOLIC RISKS TO DRIVE MARKET
 
 
 
 
 
18.5.3
REST OF SOUTH AMERICA
 
 
 
 
 
18.6
REST OF THE WORLD
 
 
 
 
 
 
 
18.6.1
MIDDLE EAST
 
 
 
 
 
 
 
18.6.1.1
RISING DISPOSABLE INCOMES AND HEALTHCARE COSTS TO DRIVE MARKET
 
 
 
 
 
18.6.2
AFRICA
 
 
 
 
 
 
 
18.6.2.1
INCREASE IN VITAMIN DEFICIENCY AND CONSUMER AWARENESS ABOUT HEALTH SUPPLEMENTS TO FUEL MARKET
 
 
 
19
COMPETITIVE LANDSCAPE
Discover top B2C and B2B strategies shaping market dominance through 2024.
 
 
 
 
 
389
 
19.1
OVERVIEW
 
 
 
 
 
 
19.2
B2C PLAYER COMPETITIVE STRATEGIES/RIGHT TO WIN, 2020–2025
 
 
 
 
 
 
19.3
REVENUE ANALYSIS (B2C MARKET), 2022–2024
 
 
 
 
 
 
 
19.4
MARKET SHARE ANALYSIS (B2C MARKET), 2024
 
 
 
 
 
 
 
19.5
MARKET SHARE ANALYSIS (B2B MARKET), 2024
 
 
 
 
 
 
 
19.6
BRAND/PRODUCT COMPARISON
 
 
 
 
 
 
 
19.7
COMPANY EVALUATION MATRIX: B2C COMPANIES, 2024
 
 
 
 
 
 
 
 
19.7.1
STARS
 
 
 
 
 
 
19.7.2
EMERGING LEADERS
 
 
 
 
 
 
19.7.3
PERVASIVE PLAYERS
 
 
 
 
 
 
19.7.4
PARTICIPANTS
 
 
 
 
 
 
19.7.5
COMPANY FOOTPRINT: B2C NUTRACEUTICAL GUMMIES COMPANIES, 2024
 
 
 
 
 
 
 
19.7.5.1
COMPANY FOOTPRINT
 
 
 
 
 
 
19.7.5.2
REGIONAL FOOTPRINT
 
 
 
 
 
 
19.7.5.3
PRODUCT TYPE FOOTPRINT
 
 
 
 
 
 
19.7.5.4
FUNCTIONALITY FOOTPRINT
 
 
 
 
19.8
COMPANY EVALUATION MATRIX: B2B COMPANIES, 2024
 
 
 
 
 
 
 
 
19.8.1
STARS
 
 
 
 
 
 
19.8.2
EMERGING LEADERS
 
 
 
 
 
 
19.8.3
PERVASIVE PLAYERS
 
 
 
 
 
 
19.8.4
PARTICIPANTS
 
 
 
 
 
 
19.8.5
COMPETITIVE BENCHMARKING
 
 
 
 
 
 
 
19.8.5.1
DETAILED LIST OF B2B KEY PLAYERS
 
 
 
 
 
19.8.6
COMPETITIVE BENCHMARKING: B2B COMPANIES, 2024
 
 
 
 
 
 
 
19.8.6.1
COMPETITIVE BENCHMARKING OF KEY B2B COMPANIES
 
 
 
 
19.9
COMPANY VALUATION AND FINANCIAL METRICS
 
 
 
 
 
 
19.10
COMPETITIVE SCENARIO
 
 
 
 
 
 
 
19.10.1
PRODUCT LAUNCHES
 
 
 
 
 
 
19.10.2
DEALS
 
 
 
 
 
 
19.10.3
EXPANSIONS
 
 
 
 
 
 
19.10.4
OTHER DEVELOPMENTS
 
 
 
 
20
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
 
 
 
 
 
419
 
20.1
B2C PLAYERS (BRAND MANUFACTURERS)
 
 
 
 
 
 
 
20.1.1
CHURCH & DWIGHT CO., INC.
 
 
 
 
 
 
 
20.1.1.1
BUSINESS OVERVIEW
 
 
 
 
 
 
20.1.1.2
PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
20.1.1.3
RECENT DEVELOPMENTS
 
 
 
 
 
 
 
 
20.1.1.3.1
PRODUCT LAUNCHES
 
 
 
 
20.1.1.4
MNM VIEW
 
 
 
 
 
 
 
 
20.1.1.4.1
KEY STRENGTHS
 
 
 
 
 
 
20.1.1.4.2
STRATEGIC CHOICES
 
 
 
 
 
 
20.1.1.4.3
WEAKNESSES AND COMPETITIVE THREATS
 
 
 
20.1.2
H&H GROUP
 
 
 
 
 
 
20.1.3
AMWAY
 
 
 
 
 
 
20.1.4
BAYER AG
 
 
 
 
 
 
20.1.5
HALEON GROUP OF COMPANIES
 
 
 
 
 
 
20.1.6
NESTLE
 
 
 
 
 
 
20.1.7
UNILEVER
 
 
 
 
 
 
20.1.8
OTSUKA HOLDINGS CO., LTD.
 
 
 
 
 
 
20.1.9
PHARMACARE LABORATORIES
 
 
 
 
 
 
20.1.10
SWANSON
 
 
 
 
 
 
20.1.11
IM HEALTHCARE
 
 
 
 
 
 
20.1.12
SMP NUTRA
 
 
 
 
 
 
20.1.13
NATURE’S TRUTH
 
 
 
 
 
 
20.1.14
HERBALAND NATURALS INC.
 
 
 
 
 
 
20.1.15
BOSCOGEN, INC.
 
 
 
 
 
20.2
B2B PLAYERS (CONTRACT MANUFACTURERS)
 
 
 
 
 
 
 
20.2.1
SOFGEN PHARMA
 
 
 
 
 
 
20.2.2
CATALENT, INC.
 
 
 
 
 
 
20.2.3
ACTIV'INSIDE
 
 
 
 
 
 
20.2.4
SIRIO PHARMA CO., LTD.
 
 
 
 
 
 
20.2.5
WIN NUTRA
 
 
 
 
 
 
20.2.6
MAKERS NUTRITION, LLC
 
 
 
 
 
 
20.2.7
ION LABS
 
 
 
 
 
 
20.2.8
VITAJOY GROUP
 
 
 
 
 
 
20.2.9
BLISS LIFESCIENCES LLP
 
 
 
 
 
 
20.2.10
GLOBAL WIDGET
 
 
 
 
 
 
20.2.11
GUMMY WORLDS
 
 
 
 
 
 
20.2.12
TOPGUM
 
 
 
 
 
 
20.2.13
MERICAL
 
 
 
 
 
 
20.2.14
FERMENTIS LIFE SCIENCES
 
 
 
 
 
 
20.2.15
EAGLE LABS, INC.
 
 
 
 
21
RESEARCH METHODOLOGY
 
 
 
 
 
502
 
21.1
RESEARCH DATA
 
 
 
 
 
 
 
21.1.1
SECONDARY DATA
 
 
 
 
 
 
 
21.1.1.1
KEY DATA FROM SECONDARY SOURCES
 
 
 
 
 
21.1.2
PRIMARY DATA
 
 
 
 
 
 
 
21.1.2.1
KEY INDUSTRY INSIGHTS
 
 
 
 
 
 
21.1.2.2
BREAKDOWN OF PRIMARY INTERVIEWS
 
 
 
 
 
 
21.1.2.3
PRIMARY SOURCES
 
 
 
 
21.2
MARKET SIZE ESTIMATION
 
 
 
 
 
 
 
21.2.1
NUTRACEUTICAL GUMMIES MARKET SIZE ESTIMATION: SUPPLY SIDE
 
 
 
 
 
 
21.2.2
NUTRACEUTICAL GUMMIES MARKET SIZE ESTIMATION: DEMAND SIDE
 
 
 
 
 
 
21.2.3
NUTRACEUTICAL GUMMIES MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
 
 
 
 
 
 
21.2.4
NUTRACEUTICAL GUMMIES MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
 
 
 
 
 
21.3
DATA TRIANGULATION
 
 
 
 
 
 
21.4
RESEARCH ASSUMPTIONS
 
 
 
 
 
 
21.5
RESEARCH LIMITATIONS
 
 
 
 
 
22
ADJACENT & RELATED MARKETS
 
 
 
 
 
513
 
22.1
INTRODUCTION
 
 
 
 
 
 
22.2
LIMITATIONS
 
 
 
 
 
 
22.3
NUTRACEUTICAL INGREDIENTS MARKET
 
 
 
 
 
 
 
22.3.1
MARKET DEFINITION
 
 
 
 
 
 
22.3.2
MARKET OVERVIEW
 
 
 
 
 
22.4
DIETARY SUPPLEMENTS MARKET
 
 
 
 
 
 
 
22.4.1
MARKET DEFINITION
 
 
 
 
 
 
22.4.2
MARKET OVERVIEW
 
 
 
 
23
APPENDIX
 
 
 
 
 
517
 
23.1
DISCUSSION GUIDE
 
 
 
 
 
 
23.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
 
 
 
 
 
 
23.3
CUSTOMIZATION OPTIONS
 
 
 
 
 
 
23.4
RELATED REPORTS
 
 
 
 
 
 
23.5
AUTHOR DETAILS
 
 
 
 
 
LIST OF TABLES
 
 
 
 
 
 
 
TABLE 1
USD EXCHANGE RATES, 2020–2024
 
 
 
 
 
 
TABLE 2
IMPACT OF PORTER’S FIVE FORCES NUTRACEUTICAL GUMMIES MARKET
 
 
 
 
 
 
TABLE 3
NUTRACEUTICAL GUMMIES MARKET: SUPPLY CHAIN (ECOSYSTEM)
 
 
 
 
 
 
TABLE 4
AVERAGE SELLING PRICE (ASP) OF NUTRACEUTICAL GUMMIES, BY KEY PLAYER, 2023 (USD/UNIT)
 
 
 
 
 
 
TABLE 5
AVERAGE SELLING PRICE (ASP) TREND OF NUTRACEUTICAL GUMMIES, BY REGION, 2021–2024 (USD/TON)
 
 
 
 
 
 
TABLE 6
IMPORT AND EXPORT SCENARIO FOR HS CODE: 210690, BY COUNTRY, 2024
 
 
 
 
 
 
TABLE 7
IMPORT AND EXPORT SCENARIO FOR HS CODE: 210690, BY COUNTRY, 2023
 
 
 
 
 
 
TABLE 8
NUTRACEUTICAL GUMMIES MARKET: LIST OF KEY CONFERENCES AND EVENTS, 2026–2027
 
 
 
 
 
 
TABLE 9
US-ADJUSTED RECIPROCAL TARIFF RATES
 
 
 
 
 
 
TABLE 10
PATENTS PERTAINING TO NUTRACEUTICAL GUMMIES, 2019–2025
 
 
 
 
 
 
TABLE 11
TOP USE CASES AND MARKET POTENTIAL
 
 
 
 
 
 
TABLE 12
BEST PRACTICES: COMPANIES IMPLEMENTING USE CASES
 
 
 
 
 
 
TABLE 13
NUTRACEUTICAL GUMMIES MARKET: CASE STUDIES RELATED TO GEN AI IMPLEMENTATION
 
 
 
 
 
 
TABLE 14
INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
 
 
 
 
 
 
TABLE 15
NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 16
EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 17
ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 18
SOUTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 19
INTERNATIONAL: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 20
GLOBAL INDUSTRY STANDARDS IN NUTRACEUTICAL GUMMIES MARKET
 
 
 
 
 
 
TABLE 21
LABELING REQUIREMENTS AND CLAIMS IN NUTRACEUTICAL GUMMIES MARKET
 
 
 
 
 
 
TABLE 22
CERTIFICATIONS, LABELING, AND ECO-STANDARDS IN NUTRACEUTICAL GUMMIES MARKET
 
 
 
 
 
 
TABLE 23
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP PRODUCT TYPES
 
 
 
 
 
 
TABLE 24
KEY BUYING CRITERIA FOR TOP PRODUCT TYPES
 
 
 
 
 
 
TABLE 25
UNMET NEEDS IN NUTRACEUTICAL GUMMIES MARKET, BY KEY INDUSTRIES ACROSS SUPPLY CHAIN
 
 
 
 
 
 
TABLE 26
COST DYNAMICS IN NUTRACEUTICAL GUMMIES MARKET
 
 
 
 
 
 
TABLE 27
MARGIN OPPORTUNITIES IN NUTRACEUTICAL GUMMIES MARKET, BY TYPE
 
 
 
 
 
 
TABLE 28
NUTRACEUTICAL GUMMIES MARKET, BY TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 29
NUTRACEUTICAL GUMMIES MARKET, BY TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 30
NUTRACEUTICAL GUMMIES MARKET, BY TYPE, 2021–2024 (TONS)
 
 
 
 
 
 
TABLE 31
NUTRACEUTICAL GUMMIES MARKET, BY TYPE, 2025–2030 (TONS)
 
 
 
 
 
 
TABLE 32
NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 33
NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 34
BRAND OWNERS & MARKETING COMPANIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 35
BRAND OWNERS & MARKETING COMPANIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 36
RETAILERS & DISTRIBUTORS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 37
RETAILERS & DISTRIBUTORS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 38
HEALTHCARE & WELLNESS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 39
HEALTHCARE & WELLNESS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 40
PHARMACEUTICAL COMPANIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 41
PHARMACEUTICAL COMPANIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 42
FOOD & BEVERAGE COMPANIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 43
FOOD & BEVERAGE COMPANIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 44
NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 45
NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 46
SMALL-SCALE CONTRACT MANUFACTURERS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 47
SMALL-SCALE CONTRACT MANUFACTURERS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 48
MID-SCALE MANUFACTURERS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 49
MID-SCALE MANUFACTURERS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 50
LARGE-SCALE INDUSTRIAL MANUFACTURERS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 51
LARGE-SCALE INDUSTRIAL MANUFACTURERS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 52
NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 53
NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 54
ANIMAL-BASED SOURCES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 55
ANIMAL-BASED SOURCES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 56
PLANT-BASED SOURCES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 57
PLANT-BASED SOURCES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 58
MICROBIAL/FERMENTATION-DERIVED SOURCES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 59
MICROBIAL/FERMENTATION-DERIVED SOURCES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 60
SYNTHETIC/CHEMICALLY-DERIVED SOURCES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 61
SYNTHETIC/CHEMICALLY-DERIVED SOURCES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 62
NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 63
NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 64
GELATIN-BASED GUMMIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 65
GELATIN-BASED GUMMIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 66
PECTIN-BASED GUMMIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 67
PECTIN-BASED GUMMIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 68
STARCH-BASED GUMMIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 69
STARCH-BASED GUMMIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 70
AGAR, CARRAGEENAN, AND OTHER HYDROCOLLOIDS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 71
AGAR, CARRAGEENAN, AND OTHER HYDROCOLLOIDS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 72
NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 73
NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 74
VITAMINS: NUTRACEUTICAL GUMMIES MARKET, BY TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 75
VITAMINS: NUTRACEUTICAL GUMMIES MARKET, BY TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 76
VITAMINS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 77
VITAMIN GUMMIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 78
MULTIVITAMINS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 79
MULTIVITAMINS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 80
VITAMIN C: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 81
VITAMIN C: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 82
VITAMIN D: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 83
VITAMIN D: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 84
VITAMIN B COMPLEX: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 85
VITAMIN B COMPLEX: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 86
VITAMIN E & A: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 87
VITAMIN E & A: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 88
MINERALS: NUTRACEUTICAL GUMMIES MARKET, BY TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 89
MINERALS: NUTRACEUTICAL GUMMIES MARKET, BY TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 90
MINERALS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 91
MINERALS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 92
CALCIUM: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 93
CALCIUM: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 94
IRON: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 95
IRON: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 96
ZINC: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 97
ZINC: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 98
MAGNESIUM: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 99
MAGNESIUM: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 100
OMEGA-3 FATTY ACIDS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 101
OMEGA-3 FATTY ACIDS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 102
PROBIOTICS & PREBIOTICS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 103
PROBIOTICS & PREBIOTICS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 104
COLLAGEN & BEAUTY-FROM-WITHIN: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 105
COLLAGEN & BEAUTY-FROM-WITHIN: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 106
HERBAL & BOTANICAL: NUTRACEUTICAL GUMMIES MARKET, BY TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 107
HERBAL & BOTANICAL: NUTRACEUTICAL GUMMIES MARKET, BY TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 108
HERBAL & BOTANICAL: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 109
HERBAL & BOTANICAL: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 110
ASHWAGANDHA: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 111
ASHWAGANDHA: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 112
TURMERIC/CURCUMIN: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 113
TURMERIC/CURCUMIN: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 114
ELDERBERRY: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 115
ELDERBERRY: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 116
MELATONIN: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 117
MELATONIN: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 118
OTHER HERBAL AND BOTANICAL GUMMIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 119
OTHER HERBAL AND BOTANICAL GUMMIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 120
DIETARY FIBER: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 121
DIETARY FIBER: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 122
CBD & CANNABIS-DERIVED: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 123
CBD & CANNABIS-DERIVED: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 124
SPECIALTY FORMULATIONS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 125
SPECIALTY FORMULATIONS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 126
NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 127
NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 128
IMMUNITY SUPPORT: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 129
IMMUNITY SUPPORT GUMMIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 130
GENERAL HEALTH & WELLNESS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 131
GENERAL HEALTH & WELLNESS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 132
BONE & JOINT HEALTH: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 133
BONE & JOINT HEALTH: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 134
WEIGHT MANAGEMENT: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 135
WEIGHT MANAGEMENT: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 136
BEAUTY & SKIN HEALTH: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 137
BEAUTY & SKIN HEALTH: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 138
OTHER FUNCTIONALITIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 139
OTHER FUNCTIONALITIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 140
NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 141
NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 142
GENERATION ALPHA (0–12 YEARS): NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 143
GENERATION ALPHA (0–12 YEARS): NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 144
GENERATION Z (13–28 YEARS): NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 145
GENERATION Z (13–28 YEARS): NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 146
MILLENNIALS (29–44 YEARS): NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 147
MILLENNIALS (29–44 YEARS): NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 148
GENERATION X (45–60 YEARS): NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 149
GENERATION X (45–60 YEARS): NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 150
BABY BOOMERS AND OLDER (61+ YEARS): NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 151
BABY BOOMERS AND OLDER (61+ YEARS): NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 152
NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 153
NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 154
OFFLINE CHANNELS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 155
OFFLINE CHANNELS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 156
OFFLINE CHANNELS: NUTRACEUTICAL GUMMIES MARKET, BY TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 157
OFFLINE CHANNELS: NUTRACEUTICAL GUMMIES MARKET, BY TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 158
HYPERMARKETS & SUPERMARKETS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 159
HYPERMARKETS & SUPERMARKETS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 160
PHARMACIES & DRUG STORES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 161
PHARMACIES & DRUG STORES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 162
SPECIALTY HEALTH STORES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 163
SPECIALTY HEALTH STORES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 164
CONVENIENCE STORES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 165
CONVENIENCE STORES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 166
MASS MERCHANDISERS AND MULTI-LEVEL MARKETING (MLM): NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 167
MASS MERCHANDISERS AND MULTI-LEVEL MARKETING (MLM): NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 168
ONLINE CHANNELS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 169
ONLINE CHANNELS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 170
B2B NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 171
B2B NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 172
B2B NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (TONS)
 
 
 
 
 
 
TABLE 173
B2B NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (TONS)
 
 
 
 
 
 
TABLE 174
B2C NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 175
B2C NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 176
B2C NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (TONS)
 
 
 
 
 
 
TABLE 177
B2C NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (TONS)
 
 
 
 
 
 
TABLE 178
NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 179
NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 180
NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2021–2024 (TONS)
 
 
 
 
 
 
TABLE 181
NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2025–2030 (TONS)
 
 
 
 
 
 
TABLE 182
NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 183
NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 184
NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2021–2024 (TONS)
 
 
 
 
 
 
TABLE 185
NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2025–2030 (TONS)
 
 
 
 
 
 
TABLE 186
NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 187
NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 188
NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2021–2024 (TONS)
 
 
 
 
 
 
TABLE 189
NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2025–2030 (TONS)
 
 
 
 
 
 
TABLE 190
NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 191
NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 192
NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021–2024 (TONS)
 
 
 
 
 
 
TABLE 193
NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025–2030 (TONS)
 
 
 
 
 
 
TABLE 194
NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 195
NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 196
NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2021–2024 (TONS)
 
 
 
 
 
 
TABLE 197
NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2025–2030 (TONS)
 
 
 
 
 
 
TABLE 198
NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 199
NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 200
NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2021–2024 (TONS)
 
 
 
 
 
 
TABLE 201
NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2025–2030 (TONS)
 
 
 
 
 
 
TABLE 202
NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 203
NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 204
NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021–2024 (TONS)
 
 
 
 
 
 
TABLE 205
NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025–2030 (TONS)
 
 
 
 
 
 
TABLE 206
NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 207
NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 208
NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN, 2021–2024 (TONS)
 
 
 
 
 
 
TABLE 209
NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN, 2025–2030 (TONS)
 
 
 
 
 
 
TABLE 210
NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL & BOTANICAL, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 211
NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL & BOTANICAL, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 212
NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL & BOTANICAL, 2021–2024 (TONS)
 
 
 
 
 
 
TABLE 213
NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL & BOTANICAL, 2025–2030 (TONS)
 
 
 
 
 
 
TABLE 214
NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 215
NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 216
NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL, 2021–2024 (TONS)
 
 
 
 
 
 
TABLE 217
NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL, 2025–2030 (TONS)
 
 
 
 
 
 
TABLE 218
NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 219
NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 220
NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2021–2024 (TONS)
 
 
 
 
 
 
TABLE 221
NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2025–2030 (TONS)
 
 
 
 
 
 
TABLE 222
NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 223
NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 224
NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2021–2024 (TONS)
 
 
 
 
 
 
TABLE 225
NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2025–2030 (TONS)
 
 
 
 
 
 
TABLE 226
NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 227
NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 228
NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS, 2021–2024 (TONS)
 
 
 
 
 
 
TABLE 229
NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS, 2025–2030 (TONS)
 
 
 
 
 
 
TABLE 230
NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 231
NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 232
NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY, 2021–2024 (TONS)
 
 
 
 
 
 
TABLE 233
NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY, 2025–2030 (TONS)
 
 
 
 
 
 
TABLE 234
US: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 235
US: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 236
US: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 237
US: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 238
CANADA: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 239
CANADA: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 240
CANADA: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 241
CANADA: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 242
MEXICO: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 243
MEXICO: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 244
MEXICO: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 245
MEXICO: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 246
EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 247
EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 248
EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2021–2024 (TONS)
 
 
 
 
 
 
TABLE 249
EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2025–2030 (TONS)
 
 
 
 
 
 
TABLE 250
EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 251
EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 252
EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2021–2024 (TONS)
 
 
 
 
 
 
TABLE 253
EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2025–2030 (TONS)
 
 
 
 
 
 
TABLE 254
EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 255
EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 256
EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2021–2024 (TONS)
 
 
 
 
 
 
TABLE 257
EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2025–2030 (TONS)
 
 
 
 
 
 
TABLE 258
EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 259
EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 260
EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021–2024 (TONS)
 
 
 
 
 
 
TABLE 261
EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025–2030 (TONS)
 
 
 
 
 
 
TABLE 262
EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 263
EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 264
EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2021–2024 (TONS)
 
 
 
 
 
 
TABLE 265
EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2025–2030 (TONS)
 
 
 
 
 
 
TABLE 266
EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 267
EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 268
EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2021–2024 (TONS)
 
 
 
 
 
 
TABLE 269
EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2025–2030 (TONS)
 
 
 
 
 
 
TABLE 270
EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 271
EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 272
EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021–2024 (TONS)
 
 
 
 
 
 
TABLE 273
EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025–2030 (TONS)
 
 
 
 
 
 
TABLE 274
EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 275
EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 276
EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN, 2021–2024 (TONS)
 
 
 
 
 
 
TABLE 277
EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN, 2025–2030 (TONS)
 
 
 
 
 
 
TABLE 278
EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL & BOTANICAL, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 279
EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL & BOTANICAL, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 280
EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL & BOTANICAL, 2021–2024 (TONS)
 
 
 
 
 
 
TABLE 281
EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL & BOTANICAL, 2025–2030 (TONS)
 
 
 
 
 
 
TABLE 282
EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 283
EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 284
EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL, 2021–2024 (TONS)
 
 
 
 
 
 
TABLE 285
EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL, 2025–2030 (TONS)
 
 
 
 
 
 
TABLE 286
EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 287
EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 288
EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2021–2024 (TONS)
 
 
 
 
 
 
TABLE 289
EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2025–2030 (TONS)
 
 
 
 
 
 
TABLE 290
EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 291
EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 292
EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2021–2024 (TONS)
 
 
 
 
 
 
TABLE 293
EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2025–2030 (TONS)
 
 
 
 
 
 
TABLE 294
EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 295
EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 296
EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS, 2021–2024 (TONS)
 
 
 
 
 
 
TABLE 297
EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS, 2025–2030 (TONS)
 
 
 
 
 
 
TABLE 298
EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 299
EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 300
EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY, 2021–2024 (TONS)
 
 
 
 
 
 
TABLE 301
EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY, 2025–2030 (TONS)
 
 
 
 
 
 
TABLE 302
GERMANY: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 303
GERMANY: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 304
GERMANY: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 305
GERMANY: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 306
UK: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 307
UK: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 308
UK: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 309
UK: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 310
FRANCE: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 311
FRANCE: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 312
FRANCE: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 313
FRANCE: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 314
SPAIN: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 315
SPAIN: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 316
SPAIN: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 317
SPAIN: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 318
ITALY: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 319
ITALY: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 320
ITALY: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 321
ITALY: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 322
REST OF EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 323
REST OF EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 324
REST OF EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 325
REST OF EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 326
ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 327
ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 328
ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2021–2024 (TONS)
 
 
 
 
 
 
TABLE 329
ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2025–2030 (TONS)
 
 
 
 
 
 
TABLE 330
ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 331
ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 332
ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2021–2024 (TONS)
 
 
 
 
 
 
TABLE 333
ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2025–2030 (TONS)
 
 
 
 
 
 
TABLE 334
ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 335
ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 336
ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2021–2024 (TONS)
 
 
 
 
 
 
TABLE 337
ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2025–2030 (TONS)
 
 
 
 
 
 
TABLE 338
ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 339
ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 340
ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021–2024 (TONS)
 
 
 
 
 
 
TABLE 341
ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025–2030 (TONS)
 
 
 
 
 
 
TABLE 342
ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 343
ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 344
ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2021–2024 (TONS)
 
 
 
 
 
 
TABLE 345
ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2025–2030 (TONS)
 
 
 
 
 
 
TABLE 346
ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 347
ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 348
ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2021–2024 (TONS)
 
 
 
 
 
 
TABLE 349
ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2025–2030 (TONS)
 
 
 
 
 
 
TABLE 350
ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 351
ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 352
ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021–2024 (TONS)
 
 
 
 
 
 
TABLE 353
ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025–2030 (TONS)
 
 
 
 
 
 
TABLE 354
ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 355
ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 356
ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN, 2021–2024 (TONS)
 
 
 
 
 
 
TABLE 357
ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN, 2025–2030 (TONS)
 
 
 
 
 
 
TABLE 358
ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL & BOTANICAL, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 359
ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL & BOTANICAL, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 360
ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL & BOTANICAL, 2021–2024 (TONS)
 
 
 
 
 
 
TABLE 361
ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL & BOTANICAL, 2025–2030 (TONS)
 
 
 
 
 
 
TABLE 362
ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 363
ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 364
ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL, 2021–2024 (TONS)
 
 
 
 
 
 
TABLE 365
ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL, 2025–2030 (TONS)
 
 
 
 
 
 
TABLE 366
ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 367
ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 368
ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2021–2024 (TONS)
 
 
 
 
 
 
TABLE 369
ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2025–2030 (TONS)
 
 
 
 
 
 
TABLE 370
ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 371
ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 372
ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2021–2024 (TONS)
 
 
 
 
 
 
TABLE 373
ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2025–2030 (TONS)
 
 
 
 
 
 
TABLE 374
ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 375
ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 376
ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS, 2021–2024 (TONS)
 
 
 
 
 
 
TABLE 377
ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS, 2025–2030 (TONS)
 
 
 
 
 
 
TABLE 378
ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 379
ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 380
ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY, 2021–2024 (TONS)
 
 
 
 
 
 
TABLE 381
ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY, 2025–2030 (TONS)
 
 
 
 
 
 
TABLE 382
CHINA: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 383
CHINA: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 384
CHINA: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 385
CHINA: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 386
JAPAN: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 387
JAPAN: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 388
JAPAN: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 389
JAPAN: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 390
INDIA: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 391
INDIA: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 392
INDIA: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 393
INDIA: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 394
AUSTRALIA & NEW ZEALAND: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 395
AUSTRALIA & NEW ZEALAND: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 396
AUSTRALIA & NEW ZEALAND: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 397
AUSTRALIA & NEW ZEALAND: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 398
REST OF ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 399
REST OF ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 400
REST OF ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 401
REST OF ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 402
SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 403
SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 404
SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2021–2024 (TONS)
 
 
 
 
 
 
TABLE 405
SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2025–2030 (TONS)
 
 
 
 
 
 
TABLE 406
SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 407
SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 408
SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2021–2024 (TONS)
 
 
 
 
 
 
TABLE 409
SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2025–2030 (TONS)
 
 
 
 
 
 
TABLE 410
SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 411
SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 412
SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2021–2024 (TONS)
 
 
 
 
 
 
TABLE 413
SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2025–2030 (TONS)
 
 
 
 
 
 
TABLE 414
SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 415
SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 416
SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021–2024 (TONS)
 
 
 
 
 
 
TABLE 417
SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025–2030 (TONS)
 
 
 
 
 
 
TABLE 418
SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 419
SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 420
SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2021–2024 (TONS)
 
 
 
 
 
 
TABLE 421
SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2025–2030 (TONS)
 
 
 
 
 
 
TABLE 422
SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 423
SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 424
SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2021–2024 (TONS)
 
 
 
 
 
 
TABLE 425
SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2025–2030 (TONS)
 
 
 
 
 
 
TABLE 426
SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 427
SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 428
SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021–2024 (TONS)
 
 
 
 
 
 
TABLE 429
SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025–2030 (TONS)
 
 
 
 
 
 
TABLE 430
SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 431
SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 432
SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN, 2021–2024 (TONS)
 
 
 
 
 
 
TABLE 433
SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN, 2025–2030 (TONS)
 
 
 
 
 
 
TABLE 434
SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL & BOTANICAL, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 435
SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL & BOTANICAL, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 436
SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL & BOTANICAL, 2021–2024 (TONS)
 
 
 
 
 
 
TABLE 437
SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL & BOTANICAL, 2025–2030 (TONS)
 
 
 
 
 
 
TABLE 438
SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 439
SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 440
SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL, 2021–2024 (TONS)
 
 
 
 
 
 
TABLE 441
SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL, 2025–2030 (TONS)
 
 
 
 
 
 
TABLE 442
SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 443
SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 444
SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2021–2024 (TONS)
 
 
 
 
 
 
TABLE 445
SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2025–2030 (TONS)
 
 
 
 
 
 
TABLE 446
SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 447
SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 448
SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2021–2024 (TONS)
 
 
 
 
 
 
TABLE 449
SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2025–2030 (TONS)
 
 
 
 
 
 
TABLE 450
SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 451
SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 452
SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS, 2021–2024 (TONS)
 
 
 
 
 
 
TABLE 453
SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS, 2025–2030 (TONS)
 
 
 
 
 
 
TABLE 454
SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 455
SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 456
SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY, 2021–2024 (TONS)
 
 
 
 
 
 
TABLE 457
SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY, 2025–2030 (TONS)
 
 
 
 
 
 
TABLE 458
BRAZIL: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 459
BRAZIL: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 460
BRAZIL: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 461
BRAZIL: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 462
ARGENTINA: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 463
ARGENTINA: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 464
ARGENTINA: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 465
ARGENTINA: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 466
REST OF SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 467
REST OF SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 468
REST OF SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 469
REST OF SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 470
REST OF THE WORLD: B2B NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 471
REST OF THE WORLD: B2B NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 472
REST OF THE WORLD: B2B NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (TONS)
 
 
 
 
 
 
TABLE 473
REST OF THE WORLD: B2B NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (TONS)
 
 
 
 
 
 
TABLE 474
REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 475
REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 476
REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (TONS)
 
 
 
 
 
 
TABLE 477
REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (TONS)
 
 
 
 
 
 
TABLE 478
REST OF THE WORLD: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 479
REST OF THE WORLD: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 480
REST OF THE WORLD: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2021–2024 (TONS)
 
 
 
 
 
 
TABLE 481
REST OF THE WORLD: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2025–2030 (TONS)
 
 
 
 
 
 
TABLE 482
REST OF THE WORLD: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 483
REST OF THE WORLD: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 484
REST OF THE WORLD: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021–2024 (TONS)
 
 
 
 
 
 
TABLE 485
REST OF THE WORLD: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025–2030 (TONS)
 
 
 
 
 
 
TABLE 486
REST OF THE WORLD: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 487
REST OF THE WORLD: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 488
REST OF THE WORLD: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2021–2024 (TONS)
 
 
 
 
 
 
TABLE 489
REST OF THE WORLD: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2025–2030 (TONS)
 
 
 
 
 
 
TABLE 490
REST OF THE WORLD: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 491
REST OF THE WORLD: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 492
REST OF THE WORLD: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2021–2024 (TONS)
 
 
 
 
 
 
TABLE 493
REST OF THE WORLD: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2025–2030 (TONS)
 
 
 
 
 
 
TABLE 494
REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 495
REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 496
REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021–2024 (TONS)
 
 
 
 
 
 
TABLE 497
REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025–2030 (TONS)
 
 
 
 
 
 
TABLE 498
REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 499
REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 500
REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN, 2021–2024 (TONS)
 
 
 
 
 
 
TABLE 501
REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN, 2025–2030 (TONS)
 
 
 
 
 
 
TABLE 502
REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL & BOTANICAL, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 503
REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL & BOTANICAL, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 504
REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL & BOTANICAL, 2021–2024 (TONS)
 
 
 
 
 
 
TABLE 505
REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL & BOTANICAL, 2025–2030 (TONS)
 
 
 
 
 
 
TABLE 506
REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 507
REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 508
REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL, 2021–2024 (TONS)
 
 
 
 
 
 
TABLE 509
REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL, 2025–2030 (TONS)
 
 
 
 
 
 
TABLE 510
REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 511
REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 512
REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2021–2024 (TONS)
 
 
 
 
 
 
TABLE 513
REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2025–2030 (TONS)
 
 
 
 
 
 
TABLE 514
REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 515
REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 516
REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2021–2024 (TONS)
 
 
 
 
 
 
TABLE 517
REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2025–2030 (TONS)
 
 
 
 
 
 
TABLE 518
REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 519
REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 520
REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS, 2021–2024 (TONS)
 
 
 
 
 
 
TABLE 521
REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS, 2025–2030 (TONS)
 
 
 
 
 
 
TABLE 522
REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 523
REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 524
REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY, 2021–2024 (TONS)
 
 
 
 
 
 
TABLE 525
REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY, 2025–2030 (TONS)
 
 
 
 
 
 
TABLE 526
MIDDLE EAST: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 527
MIDDLE EAST: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 528
MIDDLE EAST: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 529
MIDDLE EAST: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 530
AFRICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 531
AFRICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 532
AFRICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 533
AFRICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 534
OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN NUTRACEUTICAL GUMMIES MARKET, 2020–2025
 
 
 
 
 
 
TABLE 535
B2C NUTRACEUTICAL GUMMIES MARKET: DEGREE OF COMPETITION, 2024
 
 
 
 
 
 
TABLE 536
B2B NUTRACEUTICAL GUMMIES MARKET: DEGREE OF COMPETITION, 2024
 
 
 
 
 
 
TABLE 537
B2C NUTRACEUTICAL GUMMIES MARKET: REGIONAL FOOTPRINT
 
 
 
 
 
 
TABLE 538
B2C NUTRACEUTICAL GUMMIES MARKET: PRODUCT TYPE FOOTPRINT
 
 
 
 
 
 
TABLE 539
B2C NUTRACEUTICAL GUMMIES MARKET: FUNCTIONALITY FOOTPRINT
 
 
 
 
 
 
TABLE 541
NUTRACEUTICAL GUMMIES MARKET: COMPETITIVE BENCHMARKING OF B2B COMPANIES
 
 
 
 
 
 
TABLE 542
NUTRACEUTICAL GUMMIES MARKET: PRODUCT LAUNCHES, 2020– OCTOBER 2025
 
 
 
 
 
 
TABLE 543
NUTRACEUTICAL GUMMIES MARKET: DEALS, 2020–OCTOBER 2025
 
 
 
 
 
 
TABLE 544
NUTRACEUTICAL GUMMIES MARKET: EXPANSIONS, 2020–OCTOBER 2025
 
 
 
 
 
 
TABLE 545
NUTRACEUTICAL GUMMIES MARKET: OTHER DEVELOPMENTS, 2020– OCTOBER 2025
 
 
 
 
 
 
TABLE 546
CHURCH & DWIGHT CO., INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 547
CHURCH & DWIGHT CO., INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 548
CHURCH & DWIGHT CO., INC.: PRODUCT LAUNCHES
 
 
 
 
 
 
TABLE 549
H&H GROUP: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 550
H&H GROUP: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 551
H&H GROUP: DEALS
 
 
 
 
 
 
TABLE 552
H&H GROUP: EXPANSIONS
 
 
 
 
 
 
TABLE 553
H&H GROUP: OTHER DEVELOPMENTS
 
 
 
 
 
 
TABLE 554
AMWAY: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 555
AMWAY: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 556
AMWAY: PRODUCT LAUNCHES
 
 
 
 
 
 
TABLE 557
AMWAY: DEALS
 
 
 
 
 
 
TABLE 558
BAYER AG: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 559
BAYER AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 560
BAYER AG: PRODUCT LAUNCHES
 
 
 
 
 
 
TABLE 561
HALEON GROUP OF COMPANIES: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 562
HALEON GROUP OF COMPANIES: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 563
HALEON GROUP OF COMPANIES: PRODUCT LAUNCHES
 
 
 
 
 
 
TABLE 564
HALEON GROUP OF COMPANIES: DEALS
 
 
 
 
 
 
TABLE 565
HALEON GROUP OF COMPANIES: EXPANSIONS
 
 
 
 
 
 
TABLE 566
NESTLE: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 567
NESTLE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 568
NESTLE: PRODUCT LAUNCHES
 
 
 
 
 
 
TABLE 569
NESTLE: DEALS
 
 
 
 
 
 
TABLE 570
UNILEVER: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 571
UNILEVER: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 572
UNILEVER: PRODUCT LAUNCHES
 
 
 
 
 
 
TABLE 573
UNILEVER: DEALS
 
 
 
 
 
 
TABLE 574
UNILEVER: EXPANSIONS
 
 
 
 
 
 
TABLE 575
OTSUKA HOLDINGS CO., LTD.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 576
OTSUKA HOLDINGS CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 577
OTSUKA HOLDINGS CO., LTD.: PRODUCT LAUNCHES
 
 
 
 
 
 
TABLE 578
OTSUKA HOLDINGS CO., LTD.: EXPANSIONS
 
 
 
 
 
 
TABLE 579
PHARMACARE LABORATORIES: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 580
PHARMACARE LABORATORIES: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 581
PHARMACARE LABORATORIES: EXPANSIONS
 
 
 
 
 
 
TABLE 582
SWANSON: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 583
SWANSON: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 584
SWANSON: PRODUCT LAUNCHES
 
 
 
 
 
 
TABLE 585
IM HEALTHCARE: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 586
IM HEALTHCARE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 587
SMP NUTRA: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 588
SMP NUTRA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 589
NATURE’S TRUTH: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 590
NATURE’S TRUTH: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 591
NATURE’S TRUTH: OTHER DEVELOPMENTS
 
 
 
 
 
 
TABLE 592
HERBALAND NATURALS INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 593
HERBALAND NATURALS INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 594
BOSCOGEN, INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 595
BOSCOGEN, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 596
SOFGEN PHARMA: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 597
SOFGEN PHARMA: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
 
 
TABLE 598
SOFGEN PHARMA: EXPANSIONS
 
 
 
 
 
 
TABLE 599
CATALENT, INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 600
CATALENT, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
 
 
TABLE 601
CATALENT, INC.: DEALS
 
 
 
 
 
 
TABLE 602
ACTIV'INSIDE: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 603
ACTIV'INSIDE: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
 
 
TABLE 604
SIRIO PHARMA CO., LTD.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 605
SIRIO PHARMA CO., LTD.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
 
 
TABLE 606
SIRIO PHARMA CO., LTD.: PRODUCT LAUNCHES
 
 
 
 
 
 
TABLE 607
WIN NUTRA: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 608
WIN NUTRA: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
 
 
TABLE 609
MAKERS NUTRITION, LLC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 610
MAKERS NUTRITION, LLC: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
 
 
TABLE 611
ION LABS: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 612
ION LABS: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
 
 
TABLE 613
ION LABS: EXPANSIONS
 
 
 
 
 
 
TABLE 614
ION LABS: DEALS
 
 
 
 
 
 
TABLE 615
VITAJOY GROUP: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 616
VITAJOY GROUP: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
 
 
TABLE 617
BLISS LIFESCIENCES LLP: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 618
BLISS LIFESCIENCES LLP: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
 
 
TABLE 619
GLOBAL WIDGET: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 620
GLOBAL WIDGET: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
 
 
TABLE 621
GLOBAL WIDGET: PRODUCT LAUNCHES
 
 
 
 
 
 
TABLE 622
GLOBAL WIDGET: DEALS
 
 
 
 
 
 
TABLE 623
GLOBAL WIDGET: EXPANSIONS
 
 
 
 
 
 
TABLE 624
ADJACENT MARKETS TO NUTRACEUTICAL GUMMIES MARKET
 
 
 
 
 
 
TABLE 625
NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2023 (USD MILLION)
 
 
 
 
 
 
TABLE 626
NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024–2029 (USD MILLION)
 
 
 
 
 
 
TABLE 627
DIETARY SUPPLEMENTS MARKET, BY REGION, 2020–2023 (USD MILLION)
 
 
 
 
 
 
TABLE 628
DIETARY SUPPLEMENTS MARKET, BY REGION, 2024–2029 (USD MILLION)
 
 
 
 
 
 
LIST OF FIGURES
 
 
 
 
 
 
 
FIGURE 1
NUTRACEUTICAL GUMMIES MARKET SEGMENTATION
 
 
 
 
 
 
FIGURE 2
YEARS CONSIDERED
 
 
 
 
 
 
FIGURE 3
MARKET SCENARIO
 
 
 
 
 
 
FIGURE 4
B2C NUTRACEUTICAL GUMMIES MARKET, 2021–2030
 
 
 
 
 
 
FIGURE 5
B2B NUTRACEUTICAL GUMMIES MARKET, 2021-2030
 
 
 
 
 
 
FIGURE 6
MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN B2C NUTRACEUTICAL GUMMIES MARKET (2020–2025)
 
 
 
 
 
 
FIGURE 7
DISRUPTIONS INFLUENCING GROWTH OF NUTRACEUTICAL GUMMIES MARKET
 
 
 
 
 
 
FIGURE 8
HIGH-GROWTH SEGMENTS IN B2C NUTRACEUTICAL GUMMIES MARKET
 
 
 
 
 
 
FIGURE 9
ASIA PACIFIC TO REGISTER HIGHEST CAGR IN B2C NUTRACEUTICAL GUMMIES MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD
 
 
 
 
 
 
FIGURE 10
FOCUS ON CONTRACT MANUFACTURING, SCALE EFFICIENCY, AND INGREDIENT AVAILABILITY TO DRIVE B2B NUTRACEUTICAL GUMMIES MARKET
 
 
 
 
 
 
FIGURE 11
RISING CONSUMER PREFERENCE FOR CONVENIENT, FUNCTIONAL, AND PALATABLE SUPPLEMENTS TO DRIVE B2C NUTRACEUTICAL GUMMIES MARKET
 
 
 
 
 
 
FIGURE 12
MID-SCALE MANUFACTURERS SEGMENT AND NORTH AMERICA TO ACCOUNT FOR LARGEST MARKET SHARES IN 2025
 
 
 
 
 
 
FIGURE 13
VITAMINS SEGMENT AND NORTH AMERICA TO ACCOUNT FOR LARGEST MARKET SHARES IN 2025
 
 
 
 
 
 
FIGURE 14
BRAND OWNERS & MARKETING COMPANIES SEGMENT TO DOMINATE MARKET IN 2025
 
 
 
 
 
 
FIGURE 15
ANIMAL-BASED SOURCES SEGMENT TO LEAD MARKET IN 2025
 
 
 
 
 
 
FIGURE 16
GENERATION Z SEGMENT TO LEAD MARKET IN 2025
 
 
 
 
 
 
FIGURE 17
US TO DOMINATE MARKET IN 2025
 
 
 
 
 
 
FIGURE 18
US TO DOMINATE MARKET IN 2025
 
 
 
 
 
 
FIGURE 19
NUTRACEUTICAL GUMMIES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
 
 
 
 
 
 
FIGURE 20
NUTRACEUTICAL GUMMIES MARKET: PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
 
 
FIGURE 21
NUTRACEUTICAL GUMMIES (B2B & B2C) MARKET: VALUE CHAIN ANALYSIS
 
 
 
 
 
 
FIGURE 22
NUTRACEUTICAL GUMMIES MARKET: ECOSYSTEM ANALYSIS
 
 
 
 
 
 
FIGURE 23
AVERAGE SELLING PRICE OF MARKET PLAYERS, BY PRODUCT TYPES, 2024 (USD/TON)
 
 
 
 
 
 
FIGURE 24
AVERAGE SELLING PRICE TREND OF NUTRACEUTICAL GUMMIES, BY REGION, 2021–2024 (USD/TON)
 
 
 
 
 
 
FIGURE 25
EXPORT SCENARIO OF HS CODE 210690, BY KEY COUNTRY, 2020–2024 (MT)
 
 
 
 
 
 
FIGURE 26
IMPORT SCENARIO OF HS CODE 210690, BY KEY COUNTRY, 2020–2024 (MT)
 
 
 
 
 
 
FIGURE 27
TRENDS/DISRUPTIONS INFLUENCING CUSTOMER BUSINESS
 
 
 
 
 
 
FIGURE 28
INVESTMENT AND FUNDING SCENARIO
 
 
 
 
 
 
FIGURE 29
NUMBER OF PATENTS GRANTED BETWEEN 2015 AND 2025
 
 
 
 
 
 
FIGURE 30
FUTURE APPLICATIONS
 
 
 
 
 
 
FIGURE 31
IMPACT OF GENERATIVE AI ON NUTRACEUTICAL GUMMIES MARKET
 
 
 
 
 
 
FIGURE 32
SUCCESS STORIES AND REAL-WORLD APPLICATIONS
 
 
 
 
 
 
FIGURE 33
NUTRACEUTICAL GUMMIES MARKET DECISION-MAKING FACTORS
 
 
 
 
 
 
FIGURE 34
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP PRODUCT TYPES
 
 
 
 
 
 
FIGURE 35
KEY BUYING CRITERIA FOR TOP PRODUCT TYPES
 
 
 
 
 
 
FIGURE 36
ADOPTION BARRIERS AND INTERNAL CHALLENGES
 
 
 
 
 
 
FIGURE 37
NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025 VS. 2030 (USD MILLION)
 
 
 
 
 
 
FIGURE 38
NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2025 VS. 2030 (USD MILLION)
 
 
 
 
 
 
FIGURE 39
NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2025 VS. 2030 (USD MILLION)
 
 
 
 
 
 
FIGURE 40
NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2025 VS. 2030 (USD MILLION)
 
 
 
 
 
 
FIGURE 48
REVENUE ANALYSIS OF B2C MARKET PLAYERS, 2022–2024 (USD MILLION)
 
 
 
 
 
 
FIGURE 49
SHARE ANALYSIS FOR B2C MARKET PLAYERS, 2024
 
 
 
 
 
 
FIGURE 50
SHARE ANALYSIS FOR B2B MARKET PLAYERS, 2024
 
 
 
 
 
 
FIGURE 51
NUTRACEUTICAL GUMMIES MARKET: BRAND/PRODUCT COMPARISON
 
 
 
 
 
 
FIGURE 52
NUTRACEUTICAL GUMMIES MARKET: COMPANY EVALUATION MATRIX (B2C COMPANIES), 2024
 
 
 
 
 
 
FIGURE 53
B2C NUTRACEUTICAL GUMMIES MARKET: COMPANY FOOTPRINT
 
 
 
 
 
 
FIGURE 54
NUTRACEUTICAL GUMMIES MARKET: COMPANY EVALUATION MATRIX (B2B COMPANIES), 2024
 
 
 
 
 
 
FIGURE 55
COMPANY VALUATION FOR MAJOR PLAYERS IN NUTRACEUTICAL GUMMIES MARKET
 
 
 
 
 
 
FIGURE 56
EV/EBITDA OF MAJOR PLAYERS
 
 
 
 
 
 
FIGURE 57
CHURCH & DWIGHT CO., INC.: COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 58
H&H GROUP: COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 59
AMWAY: COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 60
BAYER AG: COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 61
HALEON GROUP OF COMPANIES: COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 62
NESTLE: COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 63
UNILEVER: COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 64
OTSUKA HOLDINGS CO., LTD.: COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 65
SOFGEN PHARMA: COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 66
SIRIO PHARMA CO., LTD.: COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 67
NUTRACEUTICAL GUMMIES MARKET: RESEARCH DESIGN
 
 
 
 
 
 
FIGURE 68
KEY INDUSTRY INSIGHTS
 
 
 
 
 
 
FIGURE 69
BREAKDOWN OF PRIMARY INTERVIEWS: BY VALUE CHAIN, DESIGNATION, AND REGION
 
 
 
 
 
 
FIGURE 70
SUPPLY-SIDE ANALYSIS
 
 
 
 
 
 
FIGURE 71
DEMAND-SIDE ANALYSIS
 
 
 
 
 
 
FIGURE 72
B2C NUTRACEUTICAL GUMMIES MARKET SHARE ESTIMATION: BOTTOM-UP APPROACH
 
 
 
 
 
 
FIGURE 73
B2B NUTRACEUTICAL GUMMIES MARKET SHARE ESTIMATION: BOTTOM-UP APPROACH
 
 
 
 
 
 
FIGURE 74
NUTRACEUTICAL GUMMIES MARKET SHARE ESTIMATION: TOP-DOWN APPROACH
 
 
 
 
 
 
FIGURE 75
DATA TRIANGULATION METHODOLOGY
 
 
 
 
 
 
FIGURE 76
ASSUMPTIONS
 
 
 
 
 
 
FIGURE 77
STUDY LIMITATIONS AND RISK ASSESSMENT
 
 
 
 
 
 

Methodology

This study employed two primary approaches to estimate the current size of the nutraceutical gummies market. Exhaustive secondary research was conducted to gather information on the type, consumer type, production capacity, ingredient source, gummy base/excipients, product type, functionality, demographics, and sales channel segments of the market. The next step involved validating these findings, assumptions, and sizing with industry experts across the value chain through primary research. The top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, data triangulation was used to estimate the market size of segments and subsegments.

Secondary Research

This research study used extensive secondary sources—directories and databases such as Bloomberg Businessweek and Factiva—to identify and collect information for a technical, market-oriented, and commercial market study. In the secondary research process, sources such as annual reports, press releases & investor presentations of companies, white papers, food and nutraceutical journals, certified publications, articles by recognized authors, directories, and databases were referred to identify and collect information. Secondary research was primarily used to obtain key information on the industry’s supply chain, the pool of key players, and market classification and segmentation based on industry trends, down to the bottom-most level of regional markets, and key developments from market- and technology-oriented perspectives.

Primary Research

Extensive primary research was conducted after obtaining information regarding the nutraceutical gummies market scenario through secondary research. Several primary interviews were conducted with market experts from the demand and supply sides across major countries of North America, Europe, Asia Pacific, South America, and the Rest of the World. Primary data was collected through questionnaires, emails, and telephonic interviews. The primary sources on the supply side included industry experts such as Chief Experience Officers (CXOs), vice presidents (VPs), and directors from business development, marketing, research, and development teams, as well as related key executives from distributors and key opinion leaders.

Primary interviews were conducted to gather insights, including market statistics, revenue data from products and services, market breakdowns, market size estimations, market forecasting, and data triangulation. Primary research also helped to understand the various trends related to type, customer type, production capacity, ingredient source, gummy base/excipients, product type, functionalities, demographics, sales channel, and region. Stakeholders from the demand side, including distributors, importers, exporters, research institutions, universities, and third-party vendors, were interviewed to understand buyers’ perspectives on suppliers, products, and the outlook for their businesses, which will impact the overall market.

Nutraceutical Gummies Market Size, and Share

Note: The three tiers of the companies are defined based on their total revenues in 2023 or 2024, based on the availability of financial data: Tier 1: Revenue > USD 1 billion; Tier 2: USD 100 million ≤ Revenue ≤ USD 1 billion; Tier 3: Revenue < USD 100 million. RoW includes Africa and the Middle East.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The top-down and bottom-up approaches were used to estimate and validate the total size of the nutraceutical gummies market. These approaches were also used extensively to determine the size of various subsegments in the market. The research methodology used to estimate the market size includes the following details:

  • The key players in the industry and the overall markets were identified through extensive secondary research.
  • All shares, splits, and breakdowns were determined using secondary sources and verified through primary sources.
  • All possible parameters that affect the market covered in this research study were accounted for, viewed in extensive detail, verified through primary research, and analyzed to obtain final quantitative and qualitative data.
  • The research included the study of reports, reviews, and newsletters of top market players, along with extensive interviews for opinions from leaders, such as CEOs, directors, and marketing executives.

Nutraceutical Gummies Market : Top-Down and Bottom-Up Approach

Nutraceutical Gummies Market Top Down and Bottom Up Approach

Data Triangulation

After determining the overall market size from the estimation process explained above, the total market was split into several segments and subsegments. The data triangulation procedure was employed, wherever applicable, to estimate the overall nutraceutical gummies market and obtain precise statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from the demand and supply sides. The market size was also validated using the top-down and bottom-up approaches.

Market Definition

Nutraceutical gummies are chewable dietary supplements containing bioactive ingredients such as vitamins, minerals, omega fatty acids, probiotics, prebiotics, and other substances with antioxidant properties that promote human health. Nutraceutical gummies resemble the taste and texture of gummy candies. They are offered in a variety of colors, flavors, and shapes, making them increasingly appealing, particularly to children.

They are manufactured either by contract nutraceutical manufacturers (CMOs/CDMOs) offering private-label and custom formulation services, or by brand-integrated manufacturers that control formulation, production, and commercialization under proprietary brands.

Key Stakeholders

  • Raw material suppliers
  • Contract manufacturers/suppliers
  • Health supplement suppliers
  • Commercial research & development (R&D) institutions and financial institutions
  • Traders, distributors, and retail suppliers of gummy vitamins
  • Government and research organizations
  • Associations, regulatory bodies, food safety agencies, and other industry-related bodies:
    • International Alliance for Dietary Supplements Associations (IADSA)
    • Health Foods and Dietary Supplements Association (HADSA)
    • Food and Drug Administration (FDA)
    • European Food Safety Authority (EFSA)
    • United States Department of Agriculture (USDA)
    • Food Standards Australia New Zealand (FSANZ)

Report Objectives

  • To determine and project the size of the nutraceutical gummies market based on type, customer type, production capacity, ingredient source, gummy base/excipients, product type, functionality, demographics, sales channel, and region over five years, ranging from 2025 to 2030
  • To identify the attractive opportunities in the market by determining the largest and fastest-growing segments across regions
  • To provide detailed information about the key factors influencing market growth (drivers, restraints, opportunities, and challenges)
  • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To analyze the micromarkets with respect to individual growth trends, prospects, and their contribution to the total market
  • To identify and profile the key players in the market
  • To understand the competitive landscape and identify the major growth strategies adopted by players across the key regions

Customization Options

Based on the given market data, MarketsandMarkets offers customizations tailored to company-specific scientific needs. The following customization options are available for the report:

Product Analysis

  • Product matrix that provides a detailed comparison of each company's product portfolio

Geographic Analysis

Based on the given market data, MarketsandMarkets offers customizations tailored to company-specific scientific needs.

  • Further breakdown of the Rest of Europe nutraceutical gummies market into key countries
  • Further breakdown of the Rest of Asia Pacific nutraceutical gummies market into key countries
  • Further breakdown of the Rest of South America nutraceutical gummies market into key countries

Company Information

  • Detailed analyses and profiling of additional market players (up to five)

TABLE OF CONTENTS

METHODOLOGY

Need a Tailored Report?

Customize this report to your needs

Get 10% FREE Customization

Customize This Report
Fact checked
Cite this Research

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Nutraceutical Gummies Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request
Forbes

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Nutraceutical Gummies Market

DMCA.com Protection Status